Document:

Registration Rights Agreement

 Exhibit 4.2 
 E2 OPEN, INC. 
 REGISTRATION RIGHTS AGREEMENT 

JUNE 27, 2005 
 As amended October 31, 2006 
 As amended June 26, 2008

 As amended July 7, 2008 

 TABLE OF CONTENTS 

 

									
	 	 	 	 	 	  	Page	 
			
	 1.  
	 	 Definitions
	  	 	1	  
			
	 2.
	 	 Registration Rights
	  	 	3	  
				
		 	 2.1
	 	 Request for Registration
	  	 	3	  
		 	 2.2
	 	 Company Registration
	  	 	6	  
		 	 2.3
	 	 Obligations of the Company
	  	 	6	  
		 	 2.4
	 	 Furnish Information
	  	 	8	  
		 	 2.5
	 	 Expenses of Demand Registration
	  	 	8	  
		 	 2.6
	 	 Expenses of Company Registration
	  	 	9	  
		 	 2.7
	 	 Underwriting Requirements
	  	 	9	  
		 	 2.8
	 	 Delay of Registration
	  	 	10	  
		 	 2.9
	 	 Indemnification
	  	 	10	  
		 	 2.10
	 	 Reports Under Exchange Act
	  	 	12	  
		 	 2.11
	 	 Form S-3 Registration
	  	 	13	  
		 	 2.12
	 	 Assignment of Registration Rights
	  	 	14	  
		 	 2.13
	 	 Limitations on Subsequent Registration Rights
	  	 	15	  
		 	 2.14
	 	 “Market Stand-Off” Agreement
	  	 	15	  
		 	 2.15
	 	 Termination of Registration Rights
	  	 	15	  
			
	 3.
	 	 Miscellaneous
	  	 	16	  
				
		 	 3.1
	 	 Amendments and Consents
	  	 	16	  
		 	 3.2
	 	 Notices
	  	 	16	  
		 	 3.3
	 	 Costs of Enforcement
	  	 	17	  
		 	 3.4
	 	 Integration
	  	 	17	  
		 	 3.5
	 	 Headings
	  	 	17	  
		 	3.6	 	Counterparts	  			
		 	 3.7
	 	 Severability
	  	 	17	  
		 	 3.8
	 	 Aggregation of Shares
	  	 	17	  
		 	 3.9
	 	 Applicable Law
	  	 	17	  
		 	 3.10
	 	 Dispute Resolution; Waiver of Jury Trial
	  	 	18	  
		 	 3.11
	 	 Successors and Assigns
	  	 	19	  
		 	 3.12
	 	 Transfer of Rights
	  	 	19	  
		 	 3.13
	 	 Additional Investors
	  	 	19	  
		 	 3.14
	 	 Pay-to-Play
	  	 	19	  
		
	 Schedule A - Schedule of Investors
	  			

 REGISTRATION RIGHTS AGREEMENT 

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of June 27, 2005, as amended on
October 31, 2006, June 26, 2008 and July 7, 2008, by and among E2open Inc., a Delaware corporation (the “Company”), each of the holders of the Company’s Series AA Preferred Stock and Senior Preferred Stock listed
on Schedule A hereto (each, an “Investor”) and Crosspoint Venture Partners 2000, L.P., Crosspoint Venture Partners 2000(Q), L.P., Bridge Bank, National Association, Greg Clark and any Additional Purchaser (as defined in the
Purchase Agreement) that becomes a party to this Agreement by executing and delivering to the Company a counterpart signature page hereto (which such person shall thereupon be deemed an “Investor” for all purposes of this Agreement).

 RECITALS 
 WHEREAS, the Company and certain of the Investors are parties to the Senior Preferred Stock Purchase Agreement of even date herewith (the “Purchase Agreement”); and 

WHEREAS, in order to induce the Company to enter into the Purchase Agreement and to induce certain of the Investors to
invest funds in the Company pursuant to the Purchase Agreement, the Investors and the Company hereby agree that this Agreement shall govern the rights of the Investors to cause the Company to register shares of Common Stock issuable to the
Investors: 
 NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS: 

1. Definitions. For purposes of this Agreement: 

1.1 “Affiliate” shall mean with respect to any individual, corporation, partnership, association, trust, or any
other entity (in each case, a “Person”), any Person which, directly or indirectly, controls, is controlled by or is under common control with such Person, including, without limitation any general partner, officer or director of such
Person and any venture capital fund now or hereafter existing which is controlled by or under common control with one or more general partners or shares the same management company with such Person.

1.2 “Common Stock” shall mean shares of the Company’s Common Stock, par value $0.001. 

1.3 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder.
 1.4 “Form S-3” means such form under the Securities Act as in effect on the
date hereof or any registration form under the Securities Act subsequently adopted by the SEC which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC.

 1.5 “Holder” shall mean any Person owning or having the right to
acquire Registrable Securities or any assignee thereof in accordance with Section 2.12 hereof. 
 1.6
“Immediate Family Member” shall mean a child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive
relationships, of a person referred to herein.
 1.7 “Initiating Holders” means, collectively, any
Holders who properly initiate a registration request under this Agreement.
 1.8 “IPO” means the
Company’s first underwritten public offering of its Common Stock under the Securities Act (other than a registration statement relating either to the sale of securities to employees of the Company pursuant to a stock option, stock purchase or
similar plan or an SEC Rule 145 transaction).
 1.9 “Preferred Stock” shall mean, collectively,
shares of the Company’s Series AA Preferred Stock and Senior Preferred Stock.
 1.10 The term
“register,” “registered,” and “registration” refer to a registration effected by preparing and filing a registration statement or similar document in compliance with the Securities Act, and the declaration or ordering
of effectiveness of such registration statement or document.
 1.11 “Registrable Securities” means
(i) the Common Stock issuable or issued upon conversion of the Series AA Preferred Stock and/or Senior Preferred Stock and (ii) any Common Stock of the Company issued as (or issuable upon the conversion or exercise of any warrant,
right or other security, which is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of the shares referenced in clause (i) above, excluding in all cases, however, any Registrable Securities sold
by a person in a transaction in which his rights under Section 2 hereof are not assigned or any shares for which registration rights have terminated pursuant to Section 2.15 of this agreement. 

1.12 “Registrable Securities then outstanding” means the number of shares determined by adding the number of
shares of Common Stock outstanding which are, and the number of shares of Common Stock issuable pursuant to then exercisable or convertible securities which are, Registrable Securities.

1.13 “SEC” means the Securities and Exchange Commission.

1.14 “SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities Act.

1.15 “SEC Rule 144(k)” means Rule 144(k) promulgated by the SEC under the Securities Act.

  
 -2-

 1.16 “SEC Rule 145” means Rule 145 promulgated by the
SEC under the Securities Act.
 1.17 “Securities Act” means the Securities Act of 1933, as amended,
and the rules and regulations promulgated thereunder.
 1.18 “Series AA Preferred Stock” means
shares of the Company’s Series AA Preferred Stock, par value $0.001. 
 1.19 “Senior Preferred
Stock” means shares of the Company’s Series BB Preferred Stock, par value $0.001, or Series CC Preferred Stock, par value $0.001, or both. 
 1.20 “Violation” means losses, claims, damages or liabilities (joint or several) to which a party hereto may become subject under the Securities Act, the Exchange Act or other federal or state
law, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations: (i) any untrue statement or alleged untrue statement of a
material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state therein a material fact
required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by any other party hereto of the Securities Act, the Exchange Act, any state securities law or any rule or
regulation promulgated under the Securities Act, the Exchange Act or any state securities law.
 2.
Registration Rights. The Company covenants and agrees as follows: 
 2.1 Request for
Registration.
 (a) If the Company shall receive at any time after the earlier of (i) 5 years after the date
of this Agreement or (ii) 180 days after the effective date of the Company’s IPO a written request from the Holders of at least forty percent (40%) of the Registrable Securities then outstanding that the Company file a
registration statement under the Securities Act covering the registration of Registrable Securities with a reasonably anticipated aggregate offering price of at least $5,000,000, then the Company shall: 

(i) within ten (10) days of the receipt thereof give written notice of such request to all Holders; 

(ii) as soon as practicable, and in any event within 60 days of the receipt of such request, file a registration
statement under the Securities Act covering all Registrable Securities which the Holders request to be registered, subject to the limitations of subsection 2.1(b), 

  
 -3-

 
within twenty (20) days of the mailing of such notice by the Company in accordance with Section 3.2; and 

(iii) use all commercially reasonable efforts to cause such registration statement to be declared effective by the SEC
as soon as practicable. 
 (b) If the Initiating Holders intend to distribute the Registrable Securities
covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to subsection 2.1(a) and the Company shall include such information in the written notice referred to in subsection
2.1(a). The underwriter will be selected by the Company and shall be reasonably acceptable to the Initiating Holders). In such event, the right of any Holder to include such Holder’s Registrable Securities in such registration shall be
conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities through
such underwriting shall (together with the Company as provided in subsection 2.3(e)) enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting. Notwithstanding any other provision of
this Section 2.1 if the underwriter advises the Company in writing that marketing factors require a limitation of the number of shares to be underwritten, then the Company shall so advise all Holders of Registrable Securities which would
otherwise be underwritten pursuant hereto, and the number of shares of Registrable Securities that may be included in the underwriting shall be allocated among all Holders of Registrable Securities, including the Initiating Holders, in proportion
(as nearly as practicable) to the number of Registrable Securities of the Company owned by each Holder; provided, however, that the number of shares of Registrable Securities held by the Holders to be included in such underwriting shall not be
reduced unless all other securities are first entirely excluded from the underwriting. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any
Holder to the nearest 100 shares. 
 (c) The Company shall not be obligated to effect, or to take any action to
effect, any registration 
 (i) pursuant to this Section 2.1; 

(A) In any particular jurisdiction in which the Company would be required to execute a general consent to service of
process in effecting such registration, unless the Company is already subject to service in such jurisdiction and except as may be required under the Securities Act; 

(B) After the Company has effected two registrations pursuant to this Section 2.1 and such registrations have been
declared or ordered effective, provided that a registration shall not be counted (i) until such time as such registration statement has been declared effective by the SEC (unless the Initiating Holders withdraw their request for such
registration (other than as a result of information concerning the business or financial condition of the Company which is made known to the Investors after the date on which such registration was

  
 -4-

 
requested) and elect not to pay the registration expenses therefor pursuant to Section 2.5) or (ii) if, as a result of an exercise of the underwriter’s cut-back provisions, fewer
than 50% of the total number of Registrable Securities that Holders have requested to be included in such registration statement are actually included; 
 (C) If the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered on Form S-3 pursuant to a request made pursuant to Section 2.11 below;

 (D) If the Registrable Securities to be included in the registration statement could be sold without
restriction under SEC Rule 144(k); or 
 (E) during the period starting with the date 60 days prior to the
Company’s good faith estimate of the date of the filing of and the ending on date 180 days following the effective date of a Company-initiated registration subject to Section 2.2 below, provided that the Company is actively employing in
good faith all commercially reasonable efforts to cause such registration statement effective; or 
 (ii)
pursuant to any other provision of this Agreement; 
 (A) in any particular jurisdiction in which the Company
would be required to execute a general consent to service of process in effecting such registration, unless the Company is already subject to service in such jurisdiction and except as may be required under the Securities Act; or 

(B) If the Registrable Securities to be included in the registration statement could be sold without restriction under
SEC Rule 144(k). 
 (d) Notwithstanding the foregoing, if the Company shall furnish to Holders requesting
a registration statement pursuant to this Section 2.1 a certificate signed by the Chief Executive Officer of the Company stating that in the good faith judgment of the Board of Directors of the Company it would be materially detrimental to the
Company and its stockholders for such registration statement to be filed and it is therefore necessary to defer the filing of such registration statement, the Company shall have the right to defer taking action with respect to such filing for a
period of not more than ninety (90) days after receipt of the request of the Initiating Holders; provided, however, that the Company may not utilize this right more than once in any twelve-month period and provided further that the Company
shall not register any securities for the account of itself or any other stockholder during such ninety (90) day period other than a registration statement relating either to the sale of securities to employees of the Company pursuant to a
stock option, stock purchase or similar plan or an SEC Rule 145 transaction, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale
of the Registrable Secruities, or a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered. 

  
 -5-

 2.2 Company Registration. If the Company proposes to register
(including for this purpose a registration effected by the Company for stockholders other than the Holders) any of its stock or other securities under the Securities Act in connection with the public offering of such securities solely for cash
(other than a registration statement relating either to the sale of securities to employees of the Company pursuant to a stock option, stock purchase or similar plan or an SEC Rule 145 transaction, a registration on any form which does not
include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities or a registration in which the only Common Stock being registered is Common Stock issuable
upon conversion of debt securities which are also being registered), the Company shall, at such time, promptly give each Holder written notice of such registration. Upon the written request of each Holder given within twenty (20) days after
mailing of such notice by the Company in accordance with Section 3.2, the Company shall, subject to the provisions of Section 2.7, cause to be registered under the Securities Act all of the Registrable Securities that each such Holder has
requested to be registered. The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 2.2 prior to the effectiveness of such registration whether or not any Holder has elected to include
securities in such registration. The expenses of such withdrawn registration shall be borne by the Company in accordance with Section 2.6 hereof. 
 2.3 Obligations of the Company. Whenever required under this Section 2 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably
possible, 
 (a) prepare and file with the SEC a registration statement with respect to such Registrable
Securities and use all commercially reasonable efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement
effective for a period of up to one hundred eighty (180) days or, if earlier, until the distribution contemplated in the Registration Statement has been completed; provided, however, that (i) such 180-day period shall be extended for a
period of time equal to the period the Holder refrains from selling any securities included in such registration at the request of an underwriter of Common Stock (or other securities) of the Company; and (ii) in the case of any registration of
Registrable Securities on Form S-3 which are intended to be offered on a continuous or delayed basis, subject to compliance with applicable SEC rules, such 180-day period shall be extended, if necessary, to keep the registration statement effective
until all such Registrable Securities are sold; 
 (b) prepare and file with the SEC such amendments and
supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by
such registration statement; 

  
 -6-

 (c) furnish to the Holders such numbers of copies of a prospectus,
including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 

(d) use its reasonable best efforts to register and qualify the securities covered by such registration statement under
such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 

(e) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting
agreement, in usual and customary form, with the managing underwriter of such offering. Each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement; 

(f) cause all such Registrable Securities registered pursuant to this Agreement hereunder to be listed on a national
securities exchange or trading system and each securities exchange and trading system on which similar securities issued by the Company are then listed; 
 (g) provide a transfer agent and registrar for all Registrable Securities registered pursuant hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the effective
date of such registration; 
 (h) notify each Holder of Registrable Securities covered by such registration
statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an
untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstance then existing; and 

(i) use its reasonable best efforts to furnish, at the request of any Holder requesting registration of Registrable
Securities pursuant to this Section 2, on the date on which such Registrable Securities are sold to the underwriter, (i) an opinion, dated such date, of the counsel representing the Company for the purposes of such registration, in form
and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and (ii) a “comfort” letter dated such date, from the independent certified public accountants of the
Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters, if any. 

  
 -7-

 Notwithstanding the provisions of this Section 2.3, the Company shall
be entitled to postpone or suspend, for a reasonable period of time, the filing, effectiveness or use of, or trading under, any registration statement if the Company shall determine that any such filing or the sale of any securities pursuant to such
registration statement would in the good faith judgment of the Board of Directors of the Company; 
 (i)
materially impede, delay or interfere with any material pending or proposed financing, acquisition, corporate reorganization or other similar transaction involving the Company for which the Board of Directors of the Company has authorized
negotiations; 
 (ii) materially adversely impair the consummation of any pending or proposed material offering
or sale of any class of securities by the Company; or 
 (iii) require disclosure of material nonpublic
information that, if disclosed at such time, would be materially harmful to the interests of the Company and its stockholders; provided, however, that during any such period all executive officers and directors of the Company are also prohibited
from selling securities of the Company (or any security of any of the Company’s subsidiaries or affiliates). 
 In the event of the suspension of effectiveness of any registration statement pursuant to this Section 2.3, the applicable time period during which such registration statement is to remain effective
shall be extended by that number of days equal to the number of days the effectiveness of such registration statement was suspended. 
 2.4 Furnish Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section 2 with respect to the Registrable Securities of
any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities as shall be reasonably required to effect the
registration of such Holder’s Registrable Securities. 
 2.5 Expenses of Demand
Registration. All expenses other than underwriting discounts and commissions incurred in connection with registrations, filings or qualifications pursuant to Section 2.1, including (without limitation) all registration, filing and
qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company and the reasonable fees and disbursements of one counsel appointed by a majority in interest of the selling Holders shall be borne by the
Company; provided, however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 2.1 if the registration request is subsequently withdrawn at the request of the Holders of a
majority of the Registrable Securities to be registered (in which case all participating Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn registration), unless the
Holders of a majority of the Registrable Securities agree to forfeit their right to one demand registration pursuant to Section 2.1; provided, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the
condition, business or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable promptness following disclosure by the Company of such material adverse change, then the
Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Section 2.1. 

  
 -8-

 2.6 Expenses of Company Registration. The Company shall bear and
pay all expenses incurred in connection with any registration, filing or qualification of Registrable Securities with respect to the registrations pursuant to Section 2.2 hereof for each Holder (which right may be assigned as provided in
Section 2.12 hereof), including (without limitation) all registration, filing, and qualification fees, printers and accounting fees relating or apportionable thereto and the fees and disbursements of one counsel appointed by a majority in
interest of the selling Holders selected by them, but excluding underwriting discounts and commissions relating to Registrable Securities. 
 2.7 Underwriting Requirements. In connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant to Section 2.2, the Company shall not be
required to include any of the Holders’ securities in such underwriting unless they accept the terms of the underwriting as agreed upon between the Company and its underwriters, and then only in such quantity as the underwriters determine in
their sole discretion will not jeopardize the success of the offering by the Company. If the total number of securities, including Registrable Securities, requested by stockholders to be included in such offering exceeds the amount of securities to
be sold other than by the Company that the underwriters determine in their reasonable discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities,
including Registrable Securities, which the underwriters and the Company determine in their sole discretion will not jeopardize the success of the offering. In no event shall any Registrable Securities be excluded from such offering unless all other
stockholders’ securities have been first excluded. In the event that the underwriters determine that less than all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable Securities that
are included in such offering shall be apportioned pro rata among the selling Holders based on the number of Registrable Securities held by all selling Holders or in such other proportions as shall mutually be agreed to by all such selling Holders.
Notwithstanding the foregoing, in no event shall the amount of securities of the selling Holders included in the offering be reduced below twenty-five percent (25%) of the total amount of securities included in such offering, unless such
offering is the Company’s IPO in which case the selling Holders may be excluded beyond this amount if the underwriters make the determination described above and no other stockholder’s securities are included in such offering. For purposes
of the preceding sentence concerning apportionment, for any selling stockholder which is a Holder of Registrable Securities and which is an investment fund, partnership, limited liability company or corporation, the partners, members, retired
partners, retired members, stockholders and Affiliates of such Holder, or the estates and Immediate Family Members of any such partners, retired partners, members and retired members and any trusts for the benefit of any of the foregoing persons
shall be deemed to be a single “selling Holder”, and any pro-rata reduction with respect to such “selling Holder” shall be based upon the aggregate amount of shares carrying registration rights owned by all entities and
individuals included in such “selling Holder,’ as defined in this sentence. 

  
 -9-

 2.8 Delay of Registration. No Holder shall have any right to
obtain or seek an injunction restraining or otherwise delaying any registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.9 Indemnification. In the event any Registrable Securities are included in a registration statement tinder
this Section 2: 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each
Holder, the partners, members, officers, directors and stockholders of each Holder, legal counsel and accountants for each Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such Holder
or underwriter within the meaning of the Securities Act or the Exchange Act, against any Violation and the Company will pay to each such Holder, underwriter, controlling person or other aforementioned person, any legal or other expenses reasonably
incurred by them in connection with investigating or defending any such loss, claim, damage, liability, or action as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection 2.9(a) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability, or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case
for any such loss, claim, damage, liability, or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such
registration by any such Holder, underwriter, controlling person or other aforementioned person; provided further, however, that the foregoing indemnity agreement with respect to any preliminary prospectus shall not inure to the benefit of any
Holder or underwriter or other aforementioned person, or any person controlling such Holder or underwriter, from whom the person asserting any such losses, claims, damages or liabilities purchased shares in the offering, if a copy of the most
current prospectus was not sent or given by or on behalf of such Holder or underwriter or other aforementioned person to such person, if required by law to have been so delivered, at or prior to the written confirmation of the sale of the shares to
such person, and if the prospectus (as so amended or supplemented) would have cured the defect giving rise to such loss, claim, damage or liability. 
 (b) To the extent permitted by law, each selling Holder will severally and not jointly indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration
statement, each person, if any, who controls the Company within the meaning of the Securities Act, legal counsel and accountants for the Company, any underwriter, any other Holder selling securities in such registration statement and any controlling
person of any such underwriter or other Holder, against any losses, claims, damages, or liabilities (joint or several) to 

  
 -10-

 
which any of the foregoing persons may become subject, under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages, or liabilities (or
actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly
for use in connection with such registration; and each such Holder will pay, any legal or other expenses reasonably incurred by any person intended to be indemnified pursuant to this subsection 2.9(b), in connection with investigating or defending
any such loss, claim, damage, liability, or action; provided, however, that the indemnity agreement contained in this subsection 2.9(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; provided, further, that, in no event shall any indemnity under this subsection 2.9(b) exceed the net proceeds from the offering received by
such Holder. 
 (c) Promptly after receipt by an indemnified party under this Section 2.9 of notice of the
commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.9, deliver to the indemnifying party a written notice
of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with
counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties which may be represented without conflict by one counsel) shall have the right to retain one separate counsel,
with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such
indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its ability to
defend such action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 2.9, but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may
have to any indemnified party otherwise than under this Section 2.9. 
 (d) In order to provide for just
and equitable contribution to joint liability under the Securities Act in any case in which either (i) any Holder exercising rights under this Agreement, or any controlling person of any such Holder, makes a claim for indemnification pursuant
to this Section 2.9 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may
not be enforced in such case notwithstanding the fact that this Section 2.9 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any such selling Holder or any such
controlling person in circumstances for which indemnification is provided under this Section 2.9, then, and in each such case, the Company and such Holder will contribute to the aggregate losses, claims, damages or liabilities to which they may
be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with the statements or omissions that
resulted in such loss, liability, claim, damage, or expense as well as any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the 

  
 -11-

 
indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission; provided
however, that, in any such case, (I) no such Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement, and
(II) no person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity who was not guilty of such fraudulent misrepresentation;
provided further, that in no event shall a Holder’s liability pursuant to this Section 2.9(d), when combined with the amounts paid or payable by such holder pursuant to Section 2.9(b), exceed the proceeds from the offering (net of any
underwriting discounts or commissions) received by such Holder. 
 (e) Notwithstanding the foregoing, to the
extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting
agreement shall control. 
 (f) Unless otherwise superseded by an underwriting agreement entered into in
connection with the underwritten public offering, the obligations of the Company and Holders under this Section 2.9 shall survive the completion of any offering of Registrable Securities in a registration statement under this Section 2,
and otherwise and shall survive the termination of this Agreement. 
 2.10 Reports Under Exchange
Act. With a view to making available to the Holders the benefits of Sec Rule 144 promulgated under the Securities Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to
the public without registration or pursuant to a registration on Form S-3, the Company agrees to: 
 (a) make
and keep public information available, as those terms are understood and defined in SEC Rule 144, at all times after the effective date of the Company’s IPO; 

(b) take such commercially reasonable action, including the voluntary registration of its Common Stock under
Section 12 of the Exchange Act, as is necessary to enable the Holders to utilize Form S-3 for the sale of their Registrable Securities, such action to be taken as soon as practicable after the end of the fiscal year in which the first
registration statement filed by the Company for the offering of its securities to the general public is declared effective 

  
 -12-

 (c) file with the SEC in a timely manner all reports and other documents
required of the Company under the Securities Act and the Exchange Act; and 
 (d) furnish to any Holder, so
long as the Holder owns any Registrable Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144, the Securities Act and the Exchange Act (at any time
after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report
of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC which permits the selling of any such
securities without registration or pursuant to such form. 
 2.11 Form S-3 Registration. In case the
Company shall receive from Holders of at least 15% of all Registrable Securities then outstanding a written request or requests that the Company effect a registration on Form S-3 and any related qualification or compliance with respect to all or a
part of the Registrable Securities owned by such Holder or Holders, the Company will: 
 (a) promptly give
written notice of the proposed registration, and any related qualification or compliance, to all other Holders in accordance with Section 3.2; and 
 (b) as soon as practicable, effect such registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion
of such Holder’s or Holders’ Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any other Holder or Holders joining in such request as are specified in a written
request given within 15 days after receipt of such written notice from the Company; provided, however, that the Company shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 2.11:
(1) if Form S-3 is not then available for such offering by the Holders; (2) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities
and such other securities (if any) at an aggregate price to the public (net of any underwriters’ discounts or commissions) of less than $2 million; (3) if the Company shall furnish to the Holders a certificate signed by the President of
the Company stating that in the good faith judgment of the Board of Directors of the Company, it would be materially detrimental to the Company and its stockholders for such Form S-3 Registration to be effected at such time, in which event the
Company shall have the right to defer the filing of the Form S-3 registration statement for a period of not more than 90 days after receipt of the request of the Holder or Holders under this Section 2.11; provided, however, that the Company
shall not utilize this right more than once in any twelve month period and provided further that the Company shall not register any securities for the account of itself or any other stockholder during such 90 clay period (other than a registration
relating solely to the sale of securities of participants in a Company stock plan, or a registration relating to a corporate reorganization or transaction under Rule 145 of the Securities

  
 -13-

 
Act), a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable
Securities, or a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered); (4) if the Company has, within the twelve (12) month period
preceding the date of such request, already effected two registrations on Form S-3 for the Holders pursuant to this Section 2.11; (5) in any particular jurisdiction in which the Company would be required to qualify to do business or to
execute a general consent to service of process in effecting such registration, qualification or compliance; or (6) during the period ending one hundred eighty (180) days after the effective date of a registration statement subject to
Section 2.2 hereof. 
 (c) Subject to the foregoing, the Company shall file a registration statement
covering the Registrable Securities and other securities so requested to be registered as soon as practicable after receipt of the request or requests of the Holders. All expenses incurred in connection with a registration requested pursuant to
Section 2.11, including (without limitation) all registration, filing, qualification, printer’s and accounting fees and the reasonable fees and disbursements of one counsel appointed by a majority in interest of the selling Holders and
counsel for the Company, but excluding any underwriters’ discounts or commissions associated with Registrable Securities, shall be borne by the Company. Registrations effected pursuant to this Section 2.11 shall not be counted as demands
for registration or registrations effected pursuant to Sections 2.1. 
 (d) If the Initiating Holders
intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as part of their request made pursuant to this Section 2.11 and the Company shall include such information in
the written notice referred to in Section 2.11(a). The provisions of Section 2.1(b) shall be applicable to such request (with the substitution of Section 2.11 for references to Section 2.1). 

2.12 Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities
pursuant to this Section 2 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee of such securities that (i) is a subsidiary, Affiliate, parent, partner, member, limited partner, retired partner,
retired member or stockholder of a Holder, (ii) is a Holder’s Immediate Family Member or trust for the benefit of an individual Holder or (iii) after such assignment or transfer, holds at least 7,500,000 shares of Registrable
Securities (subject to appropriate adjustment for stock splits, stock dividends, combinations or the like), provided; (a) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of
such transferee or assignee and the securities with respect to which such registration rights are being assigned; (b) such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement,
including without limitation the provisions of Section 2.14 below; and (c) such assignment shall be effective only if immediately following such transfer the further disposition of such securities by the transferee or assignee is
restricted under the Securities Act. 

  
 -14-

 2.13 Limitations on Subsequent Registration Rights. From and
after the date of this Agreement, the Company shall not, without the prior written consent of the Holders of a majority of the Registrable Securities then outstanding, enter into any agreement with any holder or prospective holder of any securities
of the Company which would allow such holder or prospective holder (a) to include such securities in any registration filed pursuant to this Agreement unless under the terms of such agreement, such holder or prospective holder may include such
securities in any such registration only to the extent that the inclusion of such securities will not reduce the amount of the Registrable Securities of the Holders that are included or (b) to demand registration of any securities held by such
holder or prospective holder. 
 2.14 “Market Stand-Off” Agreement. Each Holder agrees that such
Holder will not, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the IPO and ending on the date specified by the Company and the managing underwriter (such
period not to exceed one hundred eighty (180) days (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or
otherwise transfer or dispose of, directly or indirectly, any common equity or any securities convertible into or exercisable or exchangeable for common equity held immediately prior to the effectiveness of the registration statement for such
offering, or (ii) enter into any swap or other arrangement that transfer to another, in whole or in part, any of the economic consequences of ownership of the common equity, whether any such transaction described in clause (i) or
(ii) above is to be settled by delivery of shares of common equity or such other securities, in cash or otherwise. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the securities held
by each such Holder (and the shares of securities of every other person subject to the foregoing restriction) until the end of such period. The foregoing provisions of this Section 2.14 shall only be applicable to the Holder if all officers,
directors and greater than one percent (1%) stockholders of the Company enter into similar agreements, shall apply on to the Company IPO and shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement. The
underwriters in connection with the IPO are intended third-party beneficiaries of this Section 2.14 and shall have the right, power and authority to enforce the provisions hereof as thought they were a party hereto. Each Holder further agrees
to execute such agreements as may be reasonably requested by the underwriters in the IPO that are consistent with this Section 2.14 or that are necessary to give further effect thereto. 

2.15 Termination of Registration Rights.

(a) No Holder shall be entitled to exercise any right provided for in this Section 2 after five (5) years
following the consummation of the IPO. 

  
 -15-

 (b) The rights set forth in this Section 2 shall terminate
(i) upon a Liquidation Event, as such term is defined in the Company’s Second Amended and Restated Certificate of Incorporation and (ii) as to any Holder, when all Registrable Securities held by such Holder (together with any
Affiliate of such Holder with whom such Holder must aggregate its sales under SEC Rule 144) (A) represent 1% or less of the Company’s then outstanding Common Stock and can be sold pursuant to SEC Rule 144 or (B) can be sold
without restriction under SEC Rule 144(k). 
  

	 	3.	 Miscellaneous.

 3.1 Amendments and Consents. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either
retroactively or prospectively), only with the written consent of the Company and the holders of a majority of the Registrable Securities then outstanding. Any amendment or waiver effected in accordance with this paragraph shall be binding upon each
holder of any Registrable Securities then outstanding, each future holder of all such Registrable Securities, and the Company. Notwithstanding the foregoing, this Agreement may not be amended or terminated and the observance of any term hereunder
may not be waived with respect to any Investor without the written consent of such Investor, unless such amendment, termination or waiver applies to all Investors in the same fashion. Any amendment, termination or waiver effected in accordance with
this Section 3.1 shall be binding on all parties hereto, even if they do not execute such consent. No waivers of or exceptions to any term, condition or provision of this Agreement, in any one or more instances, shall be deemed to be, or
construed as, a further or continuing waiver of any such term, condition or provision. Notwithstanding anything to the contrary contained herein, if the Company shall issue additional shares of the Company’s Senior Preferred Stock after the
date hereof to an Additional Purchaser, any such Additional Purchaser may become a party to this Agreement by executing and delivering an additional counterpart signature page to this Agreement and thereafter shall be deemed an “Investor”
for all purposes hereunder. 
 3.2 Notices. All notices, requests, waivers and other communications
made pursuant to this Agreement shall be in writing and shall be conclusively deemed to have been duly given (a) when hand delivered to the other parties; (b) when sent by facsimile if sent between 8:00 a.m. and 5:00 p.m. recipient’s
local time on a business day, or on the next business day if sent by facsimile other than between 8:00 a.m. and 5:00 p.m. recipient’s local time on a business day; (c) three business days after deposit in the U.S. mail with first class or
certified mail receipt requested postage prepaid and addressed to the other parties; or (d) the next business day after deposit with a national overnight delivery service, postage prepaid, addressed to the other parties with next business day
delivery guaranteed, in each case to the address, email address or facsimile number set forth on the signature 

  
 -16-

 
page hereof in the case of the Company or on Schedule A in the case of all other parties hereto. A party may change or supplement the addresses given above, or designate additional
addresses, for purposes of this Section 3.2 by giving the other parties written notice of the new address in the manner set forth above. 
 3.3 Costs of Enforcement. If any party to this Agreement seeks to enforce its rights under this Agreement by legal proceedings, the non-prevailing party shall pay all costs and expenses
incurred by the prevailing party, including, without limitation, all reasonable attorneys’ fees. 
 3.4
Integration. This Agreement constitutes the entire agreement among the parties hereto pertaining to the subject matter hereof and supersedes all prior and contemporaneous agreements and understandings of the parties in connection
therewith. No oral covenant, representation or condition shall affect, or be effective to interpret, change or restrict, the express provisions of this Agreement. 

3.5 Headings. The titles and subtitles of this Agreement are for convenience only and shall not be
interpreted to limit or amplify the provisions of this Agreement. 
 3.6 Counterparts. This
Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all of which, taken together, shall constitute one and the same instrument. 

3.7 Severability. Each provision of this Agreement shall be considered separable, and if for any reason any
provision or provisions hereof are determined to be invalid and contrary to any existing or future law, such invalidity shall not impair the operation of or affect those portions of this Agreement which are valid. 

3.8 Aggregation of Shares. All shares of Registrable Securities held or acquired by Affiliates shall be
aggregated together for the purpose of determining the availability of any rights under this Agreement. 
 3.9
Applicable Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF DELAWARE WITHOUT GIVING EFFECT TO THE CONFLICTS OF LAW PRINCIPLES THEREOF; PROVIDED, HOWEVER, THAT THE FEDERAL
ARBITRATION ACT. AS AMENDED (THE “FAA”), SHALL APPLY IN PLACE AND INSTEAD OF ANY DELAWARE ARBITRATION LAWS OR REGULATIONS. 

  
 -17-

 3.10 Dispute Resolution; Waiver of Jury Trial. (a) To the
fullest extent permitted by the Delaware General Corporation Law and other applicable law, any controversy, claim or dispute arising out of or relating to this Agreement or any breach hereof, including any dispute concerning the scope of this
Section 3.10, shall be resolved exclusively by binding arbitration conducted before an arbitrator in accordance with the most applicable then existing Rules of Arbitration (the “Rules”) of the International Chamber of Commerce
(“ICC”) (or any successor or other institution performing comparable services). In order to commence a proceeding pursuant to this Section 3.10(a), any Person having rights under this Agreement (including, if applicable, the Company)
shall provide written notice of such intent to (i) each other Person having an interest in any such proceeding and (ii) if not a party to such proceeding, the Company. Within twenty (20) business days after notice of any such
proceeding is deemed to have been given, the parties to such proceeding shall use commercially reasonable efforts to appoint a sole arbitrator by agreement of such parties confirmed in accordance with the Rules. If an arbitrator is so appointed and
if the Company is not a party to such proceeding, the parties to such proceeding shall cause the Company to be notified of the name and contact information of such arbitrator. If the parties to such proceeding shall fail to appoint an arbitrator
within the requisite time period, they shall within twenty (20) business days after the expiration of such time period, use commercially reasonable efforts to appoint a former judge of an appellate court of the state in which the Company’s
headquarters is located, a United States District Court or a United States Court of Appeals, to serve as the arbitrator for the proceeding. In the event that the parties to such proceeding are unable to select an arbitrator pursuant to the
immediately preceding sentence, they shall petition the Chief Judge for the United States District Court for the District of Delaware to appoint the arbitrator. If such Chief Judge shall fail to appoint an arbitrator, the parties to such proceeding
shall either (i) comply with any legal process specified by a judge of such District Court to appoint an arbitrator or (ii) if no such process is specified, use commercially reasonable efforts to appoint a sole arbitrator by submitting an
application to such District Court pursuant to Section 5 of the FAA. The arbitration shall be conducted in the English language, and the arbitrator shall be bound to give effect to the express terms of the Agreement and may not award relief or
otherwise make an award that is contrary to such express terms. Judgment upon any such arbitration award may be entered by any Federal, state or foreign court having proper jurisdiction thereof. The Company and each Investor hereby consent to
jurisdiction for such purposes in any Federal or state court in the State of Delaware and irrevocably waive any objection to the laying of venue of any such action in such court or that any such court is an inconvenient forum. Unless otherwise
agreed to by the parties to an arbitration, the situs of any such arbitration shall be selected by the arbitrator, provided that such location is within 25 miles of the headquarters of the Company. The costs of the arbitration shall be borne by the
parties on such equitable basis as the arbitrator shall determine. 
 (a) WITHOUT LIMITING THE GENERALITY OF
PARAGRAPH (a) ABOVE, TO THE EXTENT PERMITTED BY APPLICABLE LAW, THE PARTIES HEREBY IRREVOCABLY WAIVE ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY. 

  
 -18-

 (c) The provisions of this Section 3.10 shall survive the termination
of this Agreement. 
 3.11 Successors and Assigns. The provisions of this Agreement shall be binding
upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective
successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 
 3.12 Transfer of Rights. Each Investor hereto hereby agrees that it will not, and may not, assign any of its rights and obligations hereunder, unless such rights and obligations are assigned
by such Investor to (a) any person or entity to which Registrable Securities are transferred by such Investor, or (b) to any Affiliate of such Investor, and, in each case, such transferee shall be deemed an “Investor” for
purposes of this Agreement; provided that such assignment of rights shall be contingent upon the transferee providing a written instrument to the Company notifying the Company of such transfer and assignment and agreeing in writing to be
bound by the terms of this Agreement. 
 3.13 Additional Investors. Upon the sale of additional
Senior Preferred to any Additional Purchaser in accordance with Section 1.3 of the Series BB Purchase Agreement, the Company, without prior action on the part of any Investor, shall require each Additional Purchaser to execute and deliver this
Agreement. Each such Additional Purchaser, upon execution and delivery of this Agreement by such Additional Purchaser, shall be deemed an Investor hereunder. 
 3.14 Pay-to-Play. In the event an Investor or its assignee does not purchase its Pro Rata Share of 15,625,000 shares of Series CC Preferred Stock proposed to be issued under that certain
Series CC Purchase Agreement, dated as of June 26, 2008, as amended (“Purchase Agreement”), by the Second Closing (as defined in the Purchase Agreement) (each a “Non-Participating Investor”), then, as of the Second Closing,
such Non-Participating Investor shall no longer be entitled to the rights set forth in this Agreement, and, accordingly, shall no longer be deemed a “Holder” under this Agreement (except for purposes of Section 2.14), and the shares
held by such Non-Participating Investor shall no longer be deemed “Registrable Securities” under this Agreement. For purposes of clarification, each Non-Participating Investor shall continue to be deemed a Holder for purposes of
Section 2.14 of this Agreement. For purposes of this Section, an Investor’s “Pro Rata Share” shall mean the percentage 

  
 -19-

 
equal to (x) the shares of Preferred Stock held by such Investor immediately prior to June 26, 2008 divided by (y) the total number of shares of Preferred Stock issued and
outstanding immediately prior to June 26, 2008. 
 [Remainder of Page Intentionally Left Blank] 

  
 -20-

 IN WITNESS WHEREOF, the parties have executed this Registration Rights
Agreement as of the date first above written. 
  

			
	 E2OPEN, INC.

		
	 By:
	 	 /s/ Peter Maloney

	 Name:
	 	 Peter Maloney

	 Title:
	 	 Chief Financial Officer

	 Address:
	 	 1600 Seaport Boulevard, Suite 500
 Redwood City, California 94063

	 Facsimile: (650) 381-3990

  

SIGNATURE PAGE TO E2OPEN REGISTRATION RIGHTS
AGREEMENT 

			
	INVESTORS:
		
	 Name:
	 	
	 Title:
	 	

  

SIGNATURE PAGE TO E2OPEN REGISTRATION RIGHTS
AGREEMENT 

 SCHEDULE A 
 Investors 
 Chancellor V, L.P. 
 Chancellor V-A, L.P. 
 Euromedia Venture Fund 

Citiventure 2000, L.P. 
 JK&B Capital IV,
L.P. 
 JK&B Capital IV QIP, L.P. 

B&M Ventures, LLC 
 Seagate Technology, LLC

 Crosspoint Venture Partners 2000, L.P. 
 Crosspoint Venture Partners 2000 (Q), L.P. 
 Greg Clark 

Bridge Bank, National Association 
 Daitung
Development and Investment Corporation 
 Litung Venture Capital Corporation 
 Shengtung Venture Capital Corporation 
 PACO c/o 80-16-200-1037662 (for the benefit of Cross Creek
Capital, L.P.) 
 PACO c/o 80-16-200-1037670 (for the benefit of Cross Creek Capital Employees’ Fund, L.C.)Second Amended and Restated Stockholders Agreement

 Exhibit 4.3 

 
  

 
 SECOND AMENDED AND RESTATED

 STOCKHOLDERS AGREEMENT 
 By and Among 
 E2open, Inc. 

and 
 The parties
listed on Schedule I hereto 
 Dated as of June 27, 2005 

As amended October 31, 2006 
 As amended February 2, 2007 
 As amended October 3, 2007 

As amended January 8, 2008 
 As amended February 27, 2008 
 As amended June 27, 2008 

As amended July 8, 2008 
 As Amended December 9, 2008 
 As Amended March 15, 2010 

As Amended October 5, 2010 
  

 
  

 TABLE OF CONTENTS 

 

							
	 	  	Page	 
		
	 ARTICLE I Definitions
	  	 	1	  
			
	 1.01
	    	 Definitions
	  	 	1	  
	 1.02
	    	 Other Definitions
	  	 	6	  
	 1.03
	    	 Terms Generally
	  	 	7	  
		
	 ARTICLE II Permitted Issuances and Repurchases; Preemptive Rights
	  	 	7	  
			
	 2.01
	    	 Management Shares
	  	 	7	  
	 2.02
	    	 Management Interests
	  	 	7	  
	 2.03
	    	 Preemptive Rights
	  	 	8	  
		
	 ARTICLE III Books and Records
	  	 	9	  
			
	 3.01
	    	 Reports to Stockholders
	  	 	9	  
	 3.02
	    	 Business Plans and Budgets
	  	 	11	  
	 3.03
	    	 Inspection
	  	 	11	  
	 3.04
	    	 Limitations
	  	 	11	  
		
	 ARTICLE IV Governance Provisions
	  	 	11	  
			
	 4.01
	    	 Board of Directors
	  	 	11	  
	 4.02
	    	 Matters Requiring the Approval of the Stockholders
	  	 	13	  
		
	 ARTICLE V Rights of First Refusal; Co-Sale Rights
	  	 	15	  
			
	 5.01
	    	 Rights of First Refusal
	  	 	15	  
	 5.02
	    	 Right of Co-Sale
	  	 	17	  
	 5.03
	    	 Non-Exercise of Rights
	  	 	19	  
	 5.04
	    	 Limitations to Rights of First Refusal and Co-Sale
	  	 	19	  
	 5.05
	    	 Prohibited Transfers
	  	 	19	  
	 5.06
	    	 Bylaw Restrictions
	  	 	20	  
		
	 ARTICLE VI [RESERVED]
	  	 	21	  
		
	 ARTICLE VII Miscellaneous
	  	 	21	  
			
	 7.01
	    	 Effectiveness
	  	 	21	  
	 7.02
	    	 Amendments and Consents
	  	 	21	  
	 7.03
	    	 Notices
	  	 	22	  
	 7.04
	    	 No Third-Party Rights
	  	 	22	  
	 7.05
	    	 Expenses of Stockholders
	  	 	22	  
	 7.06
	    	 Waivers
	  	 	22	  
	 7.07
	    	 No Bill for Accounting
	  	 	23	  
	 7.08
	    	 Integration
	  	 	23	  
	 7.09
	    	 Headings
	  	 	23	  
	 7.10
	    	 Counterparts
	  	 	23	  

  
 -i-

							
	 7.11
	    	 Severability
	  	 	23	  
	 7.12
	    	 Aggregation of Shares
	  	 	23	  
	 7.13
	    	 Waiver of Partition; Nature of Interest
	  	 	23	  
	 7.14
	    	 Confidentiality
	  	 	24	  
	 7.15
	    	 Applicable Law
	  	 	24	  
	 7.16
	    	 Dispute Resolution; Waiver of Jury Trial
	  	 	25	  
	 7.17
	    	 Public Announcements
	  	 	26	  
	 7.18
	    	 Successors and Assigns
	  	 	26	  
	 7.19
	    	 Additional Purchasers
	  	 	26	  
	 7.20
	    	 Pay to Play
	  	 	26	  

 SCHEDULES 
  

			
	 SCHEDULE I
	  	 Stockholders and Notice Information

	 SCHEDULE II
	  	 Significant Stockholders

  
 -ii-

 THIS SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT dated as of
June 27, 2005, as amended on October 31, 2006, February 2, 2007, October 3, 2007, January 8, 2008, February 27, 2008, June 27, 2008, July 8, 2008, July 21, 2008, December 9, 2008 March 15, 2010
and October 5, 2010 is entered into by and among E2open, Inc., a Delaware corporation, and the parties listed on Schedule I hereto. 
 PRELIMINARY STATEMENT 
 WHEREAS, some of the Stockholders are
parties to the Amended and Restated Stockholders Agreement dated as of August 10, 2004 by and among the Company and the Stockholders listed on Schedule I thereto (“Prior Agreement”); 

WHEREAS, certain of the Stockholders are providing funding to the Company on or about the Execution Date in exchange for
Senior Preferred; and 
 WHEREAS, the parties hereto desire to amend and restate the Prior Agreement in the
manner set forth this Agreement; 
 NOW, THEREFORE, the parties hereto hereby agree as follows: 

ARTICLE I  
 Definitions 
 1.01 Definitions. The following terms
shall have the following meanings for the purposes of this Agreement. 
 “Additional Purchaser” has
the meaning given to such term in the Senior Preferred Purchase Agreement. 
 “Affiliate” means, with
respect to any Person, any Person that, directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with such Person. The term “control” means the possession, directly or indirectly, of
the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 

“Agreement” means this Second Amended and Restated Stockholders Agreement, as the same may be amended or
otherwise modified from time to time in accordance with the terms hereof. 
 “Business Combination”
means, with respect to the Company or any Significant Subsidiary (the “subject company”), (i) any merger, consolidation or other business combination of the subject company with or into any other Person or any merger, consolidation or
other business 

 
combination of any Person with or into the subject company, if as a result of such transaction the Authorized Persons would own, directly or indirectly on a fully diluted basis, less than ninety
percent (90%) of the equity of the entity surviving such merger, consolidation or other business combination (assuming the exercise of all outstanding options, warrants or other rights to acquire equity in such entity) or less than ninety
percent (90%) of the voting power of the entity surviving such merger, consolidation or other business combination (assuming the exercise of all outstanding options, warrants or other rights to acquire equity in such entity) or, in the case of
a merger, consolidation or other business combination involving the Company, the Company is not the surviving entity of such business combination, (ii) any sale, lease, exchange, Transfer or other disposition, in a single transaction or series
of related transactions, of a substantial portion of the assets of the subject company to any Person other than (A) Permitted Technology Transfers or (B) sales, leases, transfers or other dispositions in the ordinary course of the subject
company’s business, or (iii) any sale, lease, exchange, Transfer or other disposition, in a single transaction or series of related transactions, of a substantial portion of the assets of any Person to the subject company, if as a result
of such transaction the Authorized Persons would own directly or indirectly on a fully diluted basis, less than ninety percent (90%) of the equity of the subject company or less than ninety percent (90%) of the voting power of the subject
company, other than (A) Permitted Technology Transfers or (B) sales, leases, exchanges, Transfers or other dispositions in the ordinary course of the Company’s business, but in the case of each of the foregoing clauses (ii) and
(iii), excluding any transaction referred to in paragraph (a) or (e) of Section 4.02 that may be effected without approval of the Required Stockholders pursuant to Section 4.02. For the purposes of this definition,
“Authorized Persons” means the Persons that hold, as of immediately prior to the consummation of such Business Combination, outstanding Shares (assuming the exercise of all outstanding options, warrants or other rights to acquire Shares).

 “Business Day” means any day other than a Saturday, a Sunday or a United States federal holiday.

 “Bylaws” means the bylaws of the Company, as in effect from time to time. 

“Certificate of Incorporation” means the Company’s certificate of incorporation, as in effect from time to
time. 
 “Class” means each class established with respect to a Share, whether such Share is a share
of Series AA Preferred, Senior Preferred or Common Stock. 
 “Code” means the Internal Revenue
Code of 1986, as amended from time to time. 
 “Common Stock” means shares of the Company’s
Common Stock, $0.001 par value. 
 “Company” means E2open, Inc., a Delaware corporation, as such
corporation may from time to time be constituted. 

  
 -2-

 “DGCL” means the Delaware General Corporation Law, as amended from
time to time. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to
time. 
 “Execution Date” means the date of this Agreement. 

“Fiscal Year” means the fiscal year of the Company for tax and accounting purposes, which shall be the 12-month
(or shorter) period ending on the last day of February of each year. 
 “GAAP” means United
States generally accepted accounting principles. 
 “Holder” means any Person that holds a Share and
has not received such Share in violation of any provision of this Agreement or the Bylaws. 
 “IPO”
means the initial primary public offering of the common equity of the Company, or any successor-in-interest to the Company, pursuant to an effective registration statement filed with the Securities and Exchange Commission in accordance with the
Securities Act, whether alone or in conjunction with a secondary public offering. 
 “Permitted Technology
Transfer” means (a) the grant by any Person to the Company or any Subsidiary of an exclusive or non-exclusive license or other exclusive or non-exclusive right to use such Person’s intellectual property, including the payment of
consideration therefor, or (b) the grant by the Company or any Subsidiary of a non-exclusive license or other non–exclusive right to use the intellectual property of the Company or any Subsidiary, including the payment of consideration
therefor. 
 “Permitted Transferee” means, with respect to a Stockholder, any Person to whom such
Stockholder Transfers Shares pursuant to a Transfer that complies with the Bylaws. 
 “Person” means
any individual, partnership, limited partnership, corporation, limited liability company, trust or other organization, whether or not a legal entity, and any governmental authority. 

“Preferred Stock” means shares of the Company’s Preferred Stock, $0.001 par value, whether Series AA
Preferred or Senior Preferred. 
 “Principal Financial Investor” means collectively Crosspoint Venture
Partners 2000, L.P., a Delaware limited partnership, and Crosspoint Venture Partners 2000 (Q), L.P., a Delaware limited partnership. 
 “Qualified IPO” has the meaning given to such term in the Certificate of Incorporation. 

  
 -3-

 “Major Stockholder” means, with respect to any issue, at any time,
a Series AA Stockholder or a Stockholder that purchased at least $5,000,000 of outstanding Senior Preferred shares or holds any outstanding Series AA Preferred shares. 

“Required Stockholders” means, with respect to any issue, at any time, Stockholders holding a majority of the
issued and outstanding Preferred Stock held by Stockholders entitled to vote on such issue at such time. 

“Securities Act” means the Securities Act of 1933, as amended from time to time. 

“Series AA Preferred” means shares of the Company’s Series AA Preferred Stock, $0.001 par value.

 “Series AA Stockholder” means a Stockholder that holds outstanding shares of Series AA
Preferred or securities convertible into or exercisable for shares of Series AA Preferred. 
 “Senior
Preferred Purchase Agreement” means the Senior Preferred Purchase Agreement of even date herewith by and among the Company and the Stockholders who purchased Senior Preferred pursuant thereto. 

“Senior Preferred” means shares of the Company’s Series BB Preferred Stock, par value $0.001, or
Series CC Preferred Stock, par value $0.001, or both. 
 “Share” means a share of Common Stock or
Preferred Stock. For purposes of Section 2.03 and Article V of this Agreement, “Shares” shall mean shares of, or securities convertible into or exchangeable or exercisable for any shares of, the Company’s capital stock.

 “Significant Stockholder” means each Holder that has signed this Agreement on or after
June 27, 2005 and that held at such time of signing one percent (1%) or more of the Company’s outstanding shares of capital stock. 
 “Significant Subsidiary” means each Subsidiary to which the Company has directly or indirectly contributed, loaned and/or advanced at least $9,500,000, as determined in accordance with GAAP,
provided any Subsidiary formed or acquired subsequent to the time that all Subsidiaries that are not Significant Subsidiaries have received aggregate capital contributions, loans and/or advances greater than $30,000,000 shall be deemed a
Significant Subsidiary. Notwithstanding the foregoing sentence, (A) each Subsidiary shall be deemed to be a Significant Subsidiary unless and until such time that the Company declares, in compliance with the restrictions above, that such
Subsidiary is not a Significant Subsidiary and (B) any Subsidiary that is not a Significant Subsidiary shall be deemed to be a Significant Subsidiary on and after the date that such Subsidiary has a fair market value in excess of the greater of
(i) $40,000,000 or (ii) fifteen percent (15%) of the fair market value of the Company and its Subsidiaries, taken as a whole, as determined in each case in good faith by the Board of Directors. The Board shall be required to renew or
update its valuation of any Subsidiary that is not a Significant Subsidiary immediately prior to the taking of any action with respect to such Subsidiary if, assuming such Subsidiary were a Significant Subsidiary, such action

  
 -4-

 
would require the approval of the Required Stockholders pursuant to Section 4.02(c) or 4.02(f). The burden of proving the fair market value of any Subsidiary or the Company shall be on a
party challenging the valuation of such Subsidiary or the Company by the Board of Directors. For the purposes of this definition, the fair market value of any securities of the Company or any Subsidiary issued in connection with any merger,
consolidation or other business combination of a Subsidiary shall be deemed to be contributed to the Subsidiary engaging in such merger, consolidation or other business combination. 

“Specified Acquisition” means any purchase, lease, or other acquisition of property (or any series of related
purchases, leases or other acquisitions of property), including by way of merger, consolidation or other business combination, by the Company or any Subsidiary (collectively, an “acquisition”) other than (a) any purchase, lease,
Transfer or other transaction in the ordinary course of the Company’s business, (b) any Permitted Technology Transfer, or (c) any transaction approved or ratified by the Required Stockholders pursuant to the provisions hereof.

 “Stockholder” means each of the Persons listed on Schedule I hereto. 

“subsidiary” means, with respect to any Person (the “parent”) at any date, any corporation, limited
liability company, partnership, association or other entity of which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power or, in the case of a partnership, more than 50% of
the general partnership interests are, as of such date, owned, controlled or held by the parent or one or more subsidiaries of the parent or by the parent and one or more subsidiaries of the parent. 

“Subsidiary” means any subsidiary of the Company. 

“Transfer” means, with respect to any item of property, any direct or indirect sale, exchange, transfer,
assignment, pledge, hypothecation or other disposition of all or any portion of such item of property to another Person, provided that any such transfer of a Share or a derivative thereof resulting from the death of a Stockholder that is a
natural Person to any Person that is a member of such Stockholder’s family group shall not be a Transfer. When used as a verb, the term “Transfer” shall have a correlative meaning. For the purposes of this definition, “family
group” means, with respect to an individual, (a) such individual’s spouse, siblings, ancestors and/or descendants and (b) any trust solely for the benefit of such individual’s spouse, siblings, ancestors and/or descendants,
in each case, whether natural, by marriage or adopted. 
 “wholly owned subsidiary” means, with
respect to any Person, a subsidiary of such Person of which securities (except for directors’ qualifying shares) or other ownership interests representing all of the equity and all of the ordinary voting power are, at the time any determination
is being made, owned, controlled or held by such Person or one or more wholly owned subsidiaries of such Person or by such Person and one or more wholly owned subsidiaries of such Person. 

“80% parent” on any date shall mean, with respect to a Stockholder, a Person that, directly or indirectly owns,
controls, or holds securities representing at least eighty percent (80%) of the equity and at least eighty percent (80%) of the ordinary voting power or, in the case of a partnership, at least eighty percent (80%) of the general
partnership interests of such Stockholder on such date. 

  
 -5-

 “80% subsidiary” on any date shall mean, with respect to a
Stockholder, a Person, of which securities representing at least eighty percent (80%) of the equity is and at least eighty percent (80%) of the ordinary voting power is or, in the case of a partnership, at least eighty percent
(80%) of the general partnership interests are, directly or indirectly owned, controlled or held by such Stockholder on such date. 
 1.02 Other Definitions. 
  

			
	 Term
	  	 Definition

	 Additional Transfer Notice
	  	 Section 5.01(c)

	 Appraiser
	  	 Section 2.03(c)

	 CEO Director
	  	 Section 4.01(a)

	 Confidential Information
	  	 Section 7.14

	 Directors
	  	 Section 4.01

	 FAA
	  	 Section 7.15

	 Fully Participating Stockholder
	  	 Section 5.01(d)(ii)

	 ICC
	  	 Section 7.16

	 INVESCO Director
	  	 Section 4.01(a)

	 Independent Director
	  	 Section 4.01(a)

	 Management Plans
	  	 Section 2.01

	 Offered Shares
	  	 Section 5.01(a)

	 Overallotment Notice
	  	 Section 5.01(d)(ii)

	 Participating Stockholder
	  	 Section 5.01(d)

	 Participating Stockholder Notice
	  	 Section 5.01(d)

	 Participating Stockholder Overallotment Notice
	  	 Section 5.01(d)(ii)

	 Preemptive Notice
	  	 Section 2.03(b)

	 Preemptive Stockholder
	  	 Section 2.03(b)

	 Prohibitive Transfer
	  	 Section 5.05(b)

	 Prime Rate
	  	 Section 2.03(b)

	 Remaining Shares
	  	 Section 5.01(c)

	 Rules
	  	 Section 7.16

	 Selling Holder
	  	 Section 5.02(a)

	 Selling Stockholder
	  	 Section 5.01(a)

	 Series AA Preferred Director
	  	 Section 4.01(a)

	 Transfer Notice
	  	 Section 5.01(a)

  
 -6-

 1.03 Terms Generally. (a) Definitions in this Agreement apply
equally to both the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. All references herein to Articles, Sections, Schedules and
Exhibits shall be deemed to be references to Articles and Sections of, and Schedules and Exhibits to, this Agreement unless the context shall otherwise require. The words “include,” “includes” and “including” shall
be deemed to be followed by the phrase “without limitation.” The terms “herein,” “hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to any particular section,
paragraph or subdivision. Any definition of, or reference to, any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise
modified, subject to any restrictions on such amendments, supplements or modifications set forth herein. 
 (b)
As used in this Agreement, all references to “majority in interest” or “plurality in interest” of the Stockholders (or any Stockholders holding any particular Class of Shares) and phrases of similar import shall be deemed to
refer to a percentage of the Shares (or Shares of a particular Class) held by such Stockholders immediately prior to the event or time with respect to which such reference is being made. 

ARTICLE II  
 Permitted Issuances and Repurchases; Preemptive Rights 

2.01 Management Shares. The Company may from time to time issue shares of Common Stock (including options,
warrants and other similar rights to purchase shares of Common Stock) to certain officers and employees of, and consultants and advisors to, the Company pursuant to one or more equity participation plans or other written agreements adopted by the
Board of Directors for such purpose (collectively, the “Management Plans”). 
 2.02 Management
Interests. In the event that any officer, employee or consultant of the Company ceases to be employed by the Company or any Subsidiary for any reason, whether voluntarily or involuntarily (including as a result of death or disability), subject
to any agreement between the Company and such officer, employee or consultant approved by the Board of Directors, the Company shall have the right to purchase, retire, cancel or otherwise obtain the Shares issued to such officer, employee or
consultant in accordance with the terms and conditions of the Management Plans. Shares may be pledged to secure debt obligations in connection with the purchase of Shares pursuant to a Management Plan approved by the Board of Directors. 

  
 -7-

 2.03 Preemptive Rights. (a) In connection with any issuance or
sale of additional Shares by the Company (other than any issuance pursuant to Section 2.01 or as provided in the last sentence of this Section 2.03(a)), each Major Stockholder shall have the right to purchase, on the same terms and at the
same purchase price per Share offered to each offeree, a percentage of such additional Shares equal to (i) the sum of such Major Stockholder’s Shares (including Shares issuable upon the exercise or conversion of outstanding securities) and
any Shares previously received pursuant to this Section 2.03 divided by (ii) the total number of Shares outstanding immediately prior to such issuance or sale. The foregoing preemptive rights shall not apply to (i) the issuance
of securities in connection with acquisition or strategic partnership transactions approved by the Board of Directors, (ii) the issuance of Shares in connection with a Qualified IPO, (iii) the issuance of securities pursuant to stock
splits, stock dividends or similar transactions, (iv) the issuance of Shares upon conversion of any Preferred Stock, (v) the issuance of securities pursuant to currently outstanding options, warrants, notes or other rights to acquire
securities of the Company, (vi) the issuance of securities to financial institutions or lessors in connection with commercial credit arrangements, equipment financings or similar transactions that are approved by the Board of Directors and are
for other than primarily equity financing purposes or (vii) the issuance of additional Senior Preferred pursuant to Section 1.3 of the Senior Preferred Purchase Agreement. 

(b) The Company shall deliver written notice (a “Preemptive Notice”) to each Major Stockholder having a
preemptive right pursuant to paragraph (a) above (a “Preemptive Stockholder”) of any proposed issuance or sale of additional Shares by the Company (except as otherwise provided in Section 2.03(a)), including the applicable
purchase price, aggregate amount offered, number and class of Shares available to such Preemptive Stockholder, name(s) of proposed offeree(s), proposed closing date and time for the issuance thereof (which shall be not less than forty–five
(45) days from the date such notice is deemed to have been given pursuant to Section 7.03) and any other material terms and conditions of the offer. Within thirty (30) days from the date that the Preemptive Notice is deemed to have
been given pursuant to Section 7.03, any Preemptive Stockholder wishing to exercise its preemptive right concerning such additional Shares shall deliver written notice to the Company setting forth the amount of such Shares which such Preemptive
Stockholder commits to purchase (which may be for all or any portion of such Shares offered to such Preemptive Stockholder). Each Preemptive Stockholder so exercising its right under this Section 2.03 shall be entitled and obligated to purchase
the number of Shares specified in such Preemptive Stockholder’s notice on the terms and conditions set forth in the Preemptive Notice. If such Preemptive Stockholder is unable to purchase such Shares at the time and date set forth in such
Preemptive Notice, after using commercially reasonable efforts to do so, solely because of its failure to receive governmental approvals or permits required to transfer funds to be used for the purchase of such Shares, such Preemptive Stockholder
may, by notice to the Company before such time and date, delay the time and date of purchasing such Shares by up to fifteen (15) days, provided that the purchase price for such Shares shall increase at an annualized rate equal to
(i) the prime rate reported in the Eastern Edition of The Wall Street Journal on the date such payment was originally due (the “Prime Rate”) plus (ii) three percent (3%) from the date such payment was
originally due until the date of actual payment. Any additional Shares for which a Preemptive Stockholder does not exercise its preemptive right may be issued or sold by the Company free and clear of the rights of the Preemptive Stockholders
pursuant to this Section 2.03, provided that such additional Shares are 

  
 -8-

 
issued or sold by the Company within one hundred twenty (120) days of the date of the Preemptive Notice for a price per Share no less than the price per Share set forth in the Preemptive
Notice, and otherwise on other terms and conditions (including aggregate amount offered) that, taken as a whole, are no less favorable to the Company than those set forth in the Preemptive Notice. If the Company does not sell such additional Shares
within such 120-day period, then the preemptive right provided in this Section 2.03 shall be revived and such additional Shares may not be offered unless first reoffered to the Preemptive Stockholders in accordance herewith. 

(c) In lieu of paying any non-cash consideration that is included in the purchase price for any additional Shares
subject to this Section 2.03, a Preemptive Stockholder electing to purchase any such Shares pursuant to this Section 2.03 shall pay a cash amount per Share equal to the fair market value per Share of such non-cash consideration. The fair
market value per Share of such non-cash consideration shall be determined either (i) in good faith by the Board of Directors, or (ii) otherwise by an independent appraiser (the “Appraiser”) selected in good faith by the Company,
provided that the Appraiser shall be duly qualified, internationally recognized and approved by the Board of Directors. The valuation of such non-cash consideration by the Appraiser or Board of Directors, as the case may be, shall be final
and binding on the Company and the Preemptive Stockholders absent manifest error. The Company shall include with each Preemptive Notice, if applicable, a copy of the Appraiser’s valuation report, signed by such Appraiser. 

(d) The rights provided in this Section 2.02 may not be assigned or transferred by any Preemptive Stockholder;
provided that (i) a Preemptive Stockholder that is a venture capital fund may assign or transfer such rights to an affiliated venture capital fund and (ii) a Preemptive Stockholder may assign or transfer such rights to a subsidiary,
parent, partner, limited partner, former partner, member, former member, Affiliate or stockholder of such Preemptive Stockholder. 
 ARTICLE III  
 Books and Records 

3.01 Reports to Stockholders. (a) Within 45 days after the end of each of the first three fiscal quarters of
a Fiscal Year, the Company shall deliver to each Stockholder unaudited consolidated balance sheets of the Company and its consolidated subsidiaries as at the end of such quarter and the related consolidated statements of income, balance sheets and
statements of cash flow of the Company and its consolidated subsidiaries, which shall fairly present the results of operations, cash flows and financial condition of the Company, for the period from the beginning of such Fiscal Year to the end of
such quarter, and for the period from the beginning of such quarter to the end of such quarter, together with a comparison to the same period in the previous Fiscal Year, in each case prepared in accordance with GAAP applied on a basis consistent
with the audited financial statements of the Company and its consolidated subsidiaries, subject to changes resulting from audit and normal year-end adjustments and excluding the customary notes thereto, together with a certificate of the
Company’s chief financial officer to such effect. 

  
 -9-

 (b) As soon as available, and in any event within 365 days following the end
of the Company’s fiscal year, the Company shall deliver to each Stockholder audited consolidated balance sheets of the Company and its consolidated subsidiaries as at the end of such Fiscal Year with a comparison to the previous Fiscal Year and
the related consolidated statements of income, statements of cash flow and changes in financial position of the Company and its consolidated subsidiaries for such Fiscal Year and a comparison to the previous Fiscal Year, all in reasonable detail and
accompanied by a report thereon of the Company’s independent auditors as to such consolidated financial statements presenting fairly the financial position of the Company and its consolidated subsidiaries as at the dates indicated and the
results of their operations, cash flows and changes in their financial position for the periods indicated in conformity with GAAP applied on a basis consistent with prior years (except as noted in the notes thereto), if applicable, and as to such
audit having been made in accordance with GAAP. The Company’s independent auditors shall be of national recognized standing and designated by the Board of Directors. [NOTE: On October 20, 2006, the Required Stockholders waived compliance
with Section 3.01(b) of the Stockholder Agreement to permit delivery to Qualifying Stockholders of audited consolidated financial statements of the Company (i) for fiscal year 2004, on or before July 19, 2006, and (ii) for fiscal
year 2005, on or before December 31, 2006. On February 2, 2007, the Required Stockholders waived compliance with Section 3.01(b) of the Stockholder Agreement to permit delivery to Qualifying Stockholders of audited consolidated
financial statements of the Company for fiscal year 2005, on or before February 28, 2007. On October 3, 2007, the Required Stockholders waived compliance with Section 3.01(b) of the Stockholder Agreement to permit delivery to
Qualifying Stockholders of audited consolidated financial statements of the Company for the fiscal year ended February 28, 2007, on or before December 31, 2007. On January 8, 2008, the Required Stockholders waived compliance with
Section 3.01(b) of the Stockholder Agreement to permit delivery to Qualifying Stockholders of audited consolidated financial statements of the Company for the fiscal year ended February 28, 2007, on or before January 10, 2008. On
September 4, 2008, the Required Stockholders waived compliance with Section 3.01(b) of the Stockholder Agreement to permit delivery to Qualifying Stockholders of audited consolidated financial statements of the Company for the fiscal year
ended February 29, 2008, on or before December 31, 2008. On December 9, 2008, the Required Stockholders amended Section 3.01(b) to require delivery of the reports to Stockholders to occur within 365 days following the end of the
Company’s fiscal year.] 
 (c) The Company shall deliver to each Stockholder such other information
relating to the financial condition, business or corporate affairs of the Company as the Stockholder may from time to time request; provided, that the Company shall not be obligated under this subsection (c) to provide information that
it deems in good faith to be a trade secret or similar confidential information. 

  
 -10-

 3.02 Business Plans and Budgets. No later than 45 days after the
beginning of each Fiscal Year, the Company shall deliver to the Stockholders the Company’s current business plan (or an update of a prior business plan, as applicable), as approved by the Board of Directors, and an operating budget for the
Company covering such Fiscal Year (subject, in the case of any Stockholder, to redaction of any competitively sensitive information, as determined by the Board of Directors in its reasonable discretion, to the extent such Stockholder, or any
Affiliate thereof, shall be engaged in an activity that competes with the Company). 
 3.03 Inspection.
The Company shall permit each Stockholder, at such Stockholder’s expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its
officers, all at such reasonable times as may be requested by such Stockholder; provided, that the Company shall not be obligated pursuant to this Section 3.03 to provide access to any information that it deems in good faith to be a
trade secret or similar confidential information. 
 3.04 Limitations. Notwithstanding anything else to
the contrary set forth in this Agreement, the Company’s obligations in this Article III shall only apply to Stockholders that hold Shares representing at least two percent (2%) of the aggregate number of outstanding Shares at the time the
Company is obligated to take any action described in this Article III. 
 ARTICLE IV  

Governance Provisions 
 4.01 Board of Directors. (a) On all matters relating to the election of directors of the Company, the Company agrees to use commercially reasonable efforts to cause the Board to nominate, and
the Stockholders agree to vote or act with respect to all Shares held by them so as to elect, the following designees to the Company’s Board of Directors: (i) one (1) individual designated by INVESCO Private Capital, Inc. or its
Affiliates (the “INVESCO Director”), (ii) three (3) individuals designated by the Stockholders holding Series AA Preferred (including Series AA Preferred issuable upon the exercise or conversion of outstanding
securities) (each a “Series AA Preferred Director”), (ii) the chief executive officer of the Company (the “CEO Director”), and (iii) one (1) person who is not employed by the Company, who is mutually
acceptable to a majority of the other Directors and who would qualify as chairman of an audit committee of the Company under applicable NASDAQ listing requirements (the “Independent Director” and, together with the INVESCO Director,
Series AA Preferred Directors and the CEO Director, the “Directors”), provided that (x) one of the Series AA Preferred Directors shall be an individual designated by the Principal Financial Investor for so long as the
Principal Financial Investor and its Affiliates hold the most Shares of any Stockholder, and (y)

  
 -11-

 
the authorized number of members comprising the Company’s Board of Directors may be increased to eight (8) members with the approval of a majority of the Directors, in which case the
Board of Directors shall be comprised of the Directors and two (2) persons who are mutually acceptable to a majority of the other Directors. Any vote taken to remove any Director elected pursuant to this Section 4.01(a), or to fill any
vacancy created by the resignation or death of a Director elected pursuant to this Section 4.01(a), shall also be subject to the provisions of this Section 4.01(a). 

(b) Johnston Evans shall be the INVESCO Director on the Execution Date. The INVESCO Director may be removed with or
without cause and replaced at any time by INVESCO Private Capital, Inc. or its Affiliates. 
 (c) (i) John
Mumford, Kunihiro Kamiya and Karl Chicca shall be the Series AA Preferred Directors on the Execution Date. Thereafter, each of the three Series AA Preferred Directors shall be elected separately for a term of one year at the annual meeting
of the Company’s stockholders or pursuant to any other reasonable procedure determined by the Board of Directors for the purpose of annually electing Series AA Preferred Directors. 

(ii) Only Stockholders holding Series AA Preferred (including Series AA Preferred issuable upon the exercise
or conversion of outstanding securities) shall be entitled to nominate individuals for the election of Series AA Preferred Directors. 
 (iii) Any Series AA Preferred Director may be removed at any time by vote of a majority in interest of Stockholders holding Series AA Preferred (including Series AA Preferred issuable upon
the exercise or conversion of outstanding securities); provided that any designee of the Principal Financial Investor may be removed only by the Principal Financial Investor for so long as the Principal Financial Investor has the right to designate
such Director pursuant to Section 4.01. 
 (iv) A vacancy created by a Series AA Preferred Director
shall be filled promptly by the election of a replacement Series AA Preferred Director either at a special meeting of the Company’s stockholders or pursuant to any other reasonable procedure determined by the Board of Directors. Subject to
Section 4.01(c), such replacement Series AA Preferred Director shall hold office until the next annual election of Series AA Preferred Directors, at which time such replacement Series AA Preferred Director shall be eligible for
reelection. 
 (v) Whenever Series AA Stockholders are entitled to elect one or more Series AA
Preferred Directors, each Series AA Stockholder may nominate one individual for election to the Board of Directors. Each Series AA Stockholder shall have the right to cast a number of votes equal to the total number of Shares then held by
such Series AA Stockholder, multiplied by the number of Series AA Preferred Directors to be elected at such time. All nominees shall be listed on a single ballot, and each Series AA Stockholder entitled to vote in such election may
allocate its votes among such nominees on such ballot in any manner that it deems appropriate, provided that no Series AA Stockholder shall cast votes for any single nominee in excess of the total number of Shares then held by such
Series AA Stockholder (any such excess being deemed to have not been 

  
 -12-

 
voted in such ballot). The election shall continue, through a multiple ballot process, with the nominee receiving the least number of votes in any ballot being excluded from future ballots until
the number of nominees remaining equals the number of Series AA Preferred Director positions to be filled at such election. In the event that there are two or more nominees receiving the least number of votes cast in any ballot, the electors
appointed by the Company for such election shall choose, by lot, one of such nominees, and such nominee shall be excluded from future ballots in connection with such election. 

(d) In the event the CEO Director ceases to be the chief executive officer of the Company for any reason, the
Stockholders agree to take all actions necessary and appropriate to remove such individual as the CEO Director and to elect, as the new CEO Director, the new chief executive officer of the Company, provided that any Person serving as
“acting” or “interim” chief executive officer or in any similar temporary position shall not be nominated or elected to serve as the CEO Director. 

(e) Each Major Stockholder shall be entitled to notice of and to have a single, nonvoting representative present at all
meetings of the Board of Directors. Such representatives shall be entitled to receive copies of all materials provided to the Directors and shall be provided an opportunity to address the Board of Directors at any such meeting. Notwithstanding the
foregoing, the Board of Directors shall have the authority to withhold materials from, and to meet in executive session outside the presence of, such representatives concerning any matter which the Board of Directors in good faith deems sensitive or
confidential in nature or otherwise inappropriate for review or discussion among such representatives, as a group. The INVESCO Director and each of the nonvoting representatives of the Major Stockholders holding Senior Preferred will be entitled to
reimbursement of reasonable travel expenses related to meetings of the Board of Directors of the Company. 

4.02 Matters Requiring the Approval of the Stockholders. The Company shall not, and it shall not permit any
Subsidiary to take, any of the following actions without the approval of the Required Stockholders (which approval, with respect to any Stockholder, shall be deemed granted if not affirmatively granted or denied by such Stockholder within ten
(10) Business Days of written notice of the action to be taken): 
 (a) incur, assume or guarantee any
secured or unsecured indebtedness for borrowed money outstanding at anytime in excess of $25,000,000 in the aggregate; 
 (b) effect any IPO unless the terms and conditions for the IPO (including the organization, capitalization and governance of the Company following the IPO) shall have been approved by the Required
Stockholders; 
 (c) issue or sell directly or indirectly (other than to the Company or a wholly owned
subsidiary of the Company) any equity interest in the Company or any Significant Subsidiary or any security or other right exercisable, convertible, exchangeable or redeemable for an 

  
 -13-

 
equity interest in the Company or any Subsidiary, other than the Shares and other equity interests authorized by Article III or issued in connection with a bona fide business acquisition that
does not require the approval of the Required Stockholders pursuant to Section 4.02(f); 
 (d) except as
permitted pursuant to Section 2.02, directly or indirectly redeem, purchase, retire or otherwise acquire for value (other than from a wholly owned subsidiary of the Company) any Share or other equity interest in the Company or any Subsidiary or
set aside any amount for any such purpose; 
 (e) effect any Specified Acquisition if the aggregate cash
consideration (including the assumption of liabilities, as determined in accordance with GAAP) paid by the Company and its Subsidiaries for all Specified Acquisitions, including such Specified Acquisition, consummated during the preceding
24–month period will exceed $50,000,000 (it being understood that the consideration paid by the Company or a Subsidiary in connection with a Specified Acquisition may also include equity of the Company or a Subsidiary, provided that the
provisions of the clause (f) below are not violated by such issuance); 
 (f) engage in any Business
Combination, other than with a wholly owned subsidiary of the Company, or any Liquidation Event as defined in the Certificate of Incorporation; 
 (g) declare or pay any dividends or other interim distributions; 

(h) effect any reclassification or reorganization of the equity interests of the Company (other than any
reclassification or reorganization that is made solely for the purpose of changing the domicile of the Company within the United States); 
 (i) amend the Bylaws or the Certificate of Incorporation; 
 (j)
voluntarily commence any proceeding or file any petition seeking liquidation, reorganization or other relief under any Federal, state or foreign bankruptcy, insolvency, receivership or similar law, consent to the institution of, or fail to contest
in a timely and appropriate manner, any involuntary proceeding or petition of the type described above, apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Company or any
Subsidiary, file an answer admitting the material allegations of a petition filed against it in any such proceeding, or make a general assignment for the benefit of creditors; 

(k) change the authorized number of directors or the classes or series of capital stock who elect them in a manner that
conflicts with the provisions of this Agreement; 
 (l) authorize or issue any other class of capital stock
that is senior to or on parity with the Senior Preferred, or increase the authorized number of shares of Preferred Stock; or 
 (m) commit to do any of the foregoing actions set forth in (a) through (l) of this Section 4.02. 

  
 -14-

 ARTICLE V  

Rights of First Refusal; Co-Sale Rights 
 5.01 Rights of First Refusal. (a) If at any time a Stockholder proposes to Transfer any Shares now or hereafter held by such Stockholder (a “Selling Stockholder”), then the Selling
Stockholder shall promptly give the Company and each Significant Stockholder written notice of the Selling Stockholder’s intention to make the Transfer (the “Transfer Notice”). The Transfer Notice shall include (i) a description
of the Shares to be transferred (“Offered Shares”), (ii) the name(s) and address(es) of the prospective transferee(s), (iii) the consideration to be received and (iv) the material terms and conditions upon which the proposed
Transfer is to be made. The Transfer Notice shall certify that the Selling Stockholder has received a firm offer from the prospective transferee(s) and in good faith believes a binding agreement for the Transfer is obtainable on the terms set forth
in the Transfer Notice. The Transfer Notice shall also include a copy of any written proposal, term sheet or letter of intent or other agreement relating to the proposed Transfer. In the event that the Transfer is being made pursuant to the
provisions of Section 5.04, the Transfer Notice shall state under which specific subsection the Transfer is being made. 
 (b) Company’s Right of First Refusal. The Company shall have an option for a period of ten (10) Business Days from delivery of the Transfer Notice to elect to purchase the Offered Shares
at the same price and subject to the same material terms and conditions as described in the Transfer Notice. The Company may exercise such purchase option and purchase all or any portion of the Offered Shares by notifying the Selling Stockholder in
writing before expiration of such ten (10) Business Day period as to the number of Offered Shares that it wishes to purchase. If the Company gives the Selling Stockholder notice that it desires to purchase any Offered Shares, then payment for
the Offered Shares shall be by check or wire transfer, against delivery of the Offered Shares to be purchased at a place agreed upon between the parties and at the time of the scheduled closing therefor, which shall be no later than thirty
(30) Business Days after delivery to the Company of the Transfer Notice, unless the Transfer Notice contemplated a later closing with the prospective third-party transferee(s) or unless the value of the purchase price has not yet been
established pursuant to Section 5.01(e). If the Company fails to purchase any or all of the Offered Shares by exercising the option granted in this Section 5.01(b) within the period provided, the remaining Offered Shares shall be subject
to the options granted to the Significant Stockholders pursuant to Section 5.01(d). 
 (c) Additional
Transfer Notice. Subject to the Company’s option set forth in Section 5.01(b), if at any time the Selling Stockholder proposes a Transfer, then, within five (5) Business Days after the Company has declined to purchase all or a
portion of the Offered Shares or the Company’s option to so purchase the Offered Shares has expired, the Selling Stockholder shall give each Significant Stockholder an “Additional Transfer Notice” that shall include all of the
information and certifications required in a Transfer Notice and shall additionally identify the Offered Shares that the Company has declined to purchase (the “Remaining Shares”) and briefly describe such Significant Stockholders’
rights of first refusal and co-sale rights with respect to the proposed Transfer. 

  
 -15-

 (d) Significant Stockholders’ Right of First Refusal.

 (i) Each Significant Stockholder (other than the Selling Stockholder) shall have an option for a period of
fifteen (15) Business Days from the delivery of the Additional Transfer Notice from the Selling Stockholder set forth in Section 5.01(c) to elect to purchase its respective pro rata share of the Remaining Shares at the same price and
subject to the same material terms and conditions as described in the Additional Transfer Notice. Each Significant Stockholder (other than the Selling Stockholder) may exercise such purchase option and purchase all or any portion of his, her or its
pro rata share of the Remaining Shares (a “Participating Stockholder” for purposes of Section 5.01(d) and 5.01(e)), by notifying the Selling Stockholder and the Company in writing, before expiration of the fifteen (15) Business
Day period as to the number of Remaining Shares that he, she or it wishes to purchase (the “Participating Stockholder Notice”). Each Participating Stockholder’s pro rata share of the Remaining Shares shall be a fraction of the
Remaining Shares, the numerator of which shall be the number of shares of Common Stock (including shares issuable upon exercise or conversion of outstanding securities) owned by such Participating Stockholder on the date of the Transfer Notice and
denominator of which shall be the total number of shares of Common Stock (including shares issuable upon exercise or conversion of outstanding securities) held by all Participating Stockholders (excluding the Selling Stockholder) on the date of the
Transfer Notice. 
 (ii) In the event any Significant Stockholder elects not to purchase its pro rata share of
the Remaining Shares available pursuant to its option under Section 5.01(d)(i) within the time period set forth therein, then the Selling Stockholder shall promptly give written notice (the “Overallotment Notice”) to each
Participating Stockholder that has elected to purchase all of its pro rata share of the Remaining Shares (each a “Fully Participating Stockholder”), which notice shall set forth the number of Remaining Shares not purchased by the other
Significant Stockholders, and shall offer the Fully Participating Stockholders the right to acquire the unsubscribed Remaining Shares. Each Fully Participating Stockholder shall have ten (10) Business Days after delivery of the Overallotment
Notice to deliver a written notice to the Selling Stockholder (the “Participating Stockholder Overallotment Notice”) of its election to purchase its pro rata share of the unsubscribed shares on the same terms and conditions as set forth in
the Additional Transfer Notice and indicating the maximum number of the unsubscribed shares that it will purchase in the event that any other Fully Participating Stockholder elects not to purchase its pro rata share of the unsubscribed shares. Each
Fully Participating Stockholder’s pro rata share of the unsubscribed shares shall be a fraction, the numerator of which shall be the number of shares of Common Stock (including shares issuable upon exercise or conversion of outstanding
securities) owned by such Fully Participating Stockholder on the date of the Transfer Notice and denominator of which shall be the total number of shares of Common Stock (including shares issuable upon exercise or conversion of outstanding
securities) held by all Fully Participating Stockholders on the date of the Transfer Notice. Each Participating Stockholder shall be entitled to apportion shares to be purchased among its partners and affiliates (including in the case of a venture
capital fund other venture capital funds affiliated with such fund), provided that such Participating Stockholder notifies the Selling Stockholder of such allocation. 

  
 -16-

 (e) Payment. 

(i) The Participating Stockholders shall effect the purchase of the Remaining Shares with payment by check or wire
transfer, against delivery of the Remaining Shares to be purchased at a place agreed upon between the parties and at the time of the scheduled closing therefor, which shall be no later than fifty (50) Business Days after delivery to the Company
of the Transfer Notice, unless the Transfer Notice contemplated a later closing with the prospective third-party transferee(s) or unless the value of the purchase price has not yet been established pursuant to Section 5.01(e)(ii). 

(ii) Should the purchase price specified in the Transfer Notice or Additional Transfer Notice be payable in property
other than cash or evidences of indebtedness, the Company (and the Participating Stockholders) shall have the right to pay the purchase price in the form of cash equal in amount to the fair market value of such property. If the Selling Stockholder
and the Company (or the Participating Stockholders) cannot agree on such cash value within ten (10) Business Days after delivery to the Company of the Transfer Notice (or the delivery of the Additional Transfer Notice to the Significant
Stockholders), the valuation shall be made by an appraiser of recognized standing selected by the Selling Stockholder and the Company (or the Participating Holders) or, if they cannot agree on an appraiser within fifteen (15) Business Days
after delivery to the Company of the Transfer Notice (or the Delivery of the Additional Transfer Notice to the Significant Stockholders), each shall select an appraiser of recognized standing and those appraisers shall designate a third appraiser of
recognized standing, whose appraisal shall be determinative of such value. The cost of such appraisal shall be shared pro rata by the Company and the Participating Stockholders, based on the number of shares each such party has expressed an interest
in purchasing pursuant to this Section 5.01. If the time for the closing of the Company’s purchase or the Participating Stockholders’ purchase has expired but the determination of the value of the purchase price offered by the
prospective transferee(s) has not been finalized, then such closing shall be held on or prior to the fifth Business Day after such valuation shall have been made pursuant to this subsection. 

5.02 Right of Co-Sale. (a) To the extent the Company and the Significant Stockholders do not exercise their
respective rights of refusal as to all of the Offered Shares pursuant to Section 5.01, then each Significant Stockholder (other than the Selling Stockholder) (a “Selling Holder” for purposes of this Section 5.02) that notifies
the Selling Stockholder in writing within fifteen (15) Business Days after delivery of the Additional Transfer Notice referred to in Section 5.01(a) shall have the right to participate in such sale of Shares on the same terms and
conditions as specified in the Transfer Notice. Such Selling Holder’s notice to the Selling Stockholder shall indicate the number of shares of capital stock of the Company that the Selling Holder wishes to sell under his, her or its right to
participate. To the extent one or more of the Significant Stockholders exercise such right of participation in accordance with the terms and conditions set forth below, the number of Shares that the Selling Stockholder may sell in the Transfer shall
be correspondingly reduced. 

  
 -17-

 (b) Each Selling Holder may sell all or any part of that number of shares
of capital stock of the Company equal to the product obtained by multiplying (i) the aggregate number of Shares covered by the Transfer Notice that have not been subscribed for pursuant to Section 5.01 by (ii) a fraction, the
numerator of which is the number of shares of Common Stock (including shares issuable upon exercise or conversion of outstanding securities) owned by the Selling Holder on the date of the Transfer Notice and the denominator of which is the total
number of shares of Common Stock (including shares issuable upon exercise or conversion of outstanding securities) owned by the Selling Stockholder and all of the Selling Holders on the date of the Transfer Notice. 

(c) Each Selling Holder shall effect its participation in the sale by promptly delivering to the Selling Stockholder for
transfer to the prospective purchaser one or more certificates, properly endorsed for transfer, which represent: 
 (i) the type and number of shares of capital stock of the Company that such Selling Holder elects to sell; or 
 (ii) that number of shares of capital stock of the Company that are at such time convertible into the number of shares of Common Stock that such Selling Holder elects to sell; provided, that if the
prospective third-party purchaser objects to the delivery of shares of capital stock of the Company in lieu of Common Stock, such Selling Holder shall convert such shares of capital stock of the Company into Common Stock and deliver Common Stock as
provided in this Section 5.02. The Company agrees to make any such conversion concurrent with the actual Transfer of such shares to the purchaser and contingent on such Transfer. 

(d) The stock certificate or certificates that the Selling Holder delivers to the Selling Stockholder pursuant to
Section 5.02(c) shall be transferred to the prospective purchaser in consummation of the sale of the Shares pursuant to the terms and conditions specified in the Transfer Notice, and the Selling Stockholder shall concurrently therewith remit to
such Selling Holder that portion of the sale proceeds to which such Selling Holder is entitled by reason of its participation in such sale. To the extent that any prospective purchaser or purchasers prohibits such assignment or otherwise refuses to
purchase shares or other securities from a Selling Holder exercising its rights of co-sale hereunder, the Selling Stockholder shall not sell to such prospective purchaser or purchasers any Shares unless and until, simultaneously with such sale, the
Selling Stockholder shall purchase such shares or other securities from such Selling Holder for the same consideration and on the same terms and conditions as the proposed transfer described in the Transfer Notice. 

  
 -18-

 5.03 Non-Exercise of Rights. To the extent that the Company and the
Significant Stockholders have not exercised their rights to purchase the Offered Shares or the Remaining Shares within the time periods specified in Section 5.01 and the Significant Stockholders have not exercised their rights to participate in
the sale of the Remaining Shares within the time periods specified in Section 5.02, the Selling Stockholder shall have a period of thirty (30) Business Days from the expiration of such rights in which to sell the Offered Shares or the
Remaining Shares, as the case may be, upon terms and conditions (including the purchase price) no more favorable than those specified in the Transfer Notice, to the third-party transferee(s) identified in the Transfer Notice. The third-party
transferee(s) shall acquire the Offered Shares and the Remaining Shares free and clear of subsequent rights of first refusal and co-sale rights under this Agreement. In the event Selling Stockholder does not consummate the sale or disposition of the
Offered Shares and Remaining Shares within the thirty (30) Business Day period from the expiration of these rights, the Company’s first refusal rights and the Significant Stockholders’ first refusal rights and co-sale rights shall
continue to be applicable to any subsequent disposition of the Offered Shares or the Remaining Shares by the Selling Stockholder until such right lapses in accordance with the terms of this Agreement. Furthermore, the exercise or non-exercise of the
rights of the Company and the Significant Stockholders to purchase Shares from the Selling Stockholder or participate in sales of Shares by the Selling Stockholder shall not adversely affect their rights to make subsequent purchases from the Selling
Stockholder of Shares or subsequently participate in sales of Shares by the Selling Stockholder. 
 5.04
Limitations to Rights of First Refusal and Co-Sale. Notwithstanding the provisions of Sections 5.01 and 5.02 of this Agreement, the first refusal rights of the Company and first refusal and co-sale rights of the Significant Stockholders
shall not apply to any Transfer of Shares to (a) a member of such Stockholder’s family group or (b) a subsidiary, Affiliate, parent, partner, member, limited partner, retired partner, retired member or stockholder of such Stockholder;
provided, that (i) the Stockholder shall inform the Company and the other Significant Stockholders of such Transfer prior to effecting it and (ii) each such transferee or assignee, prior to the completion of the Transfer, shall have
executed documents assuming the obligations of the Stockholder under this Agreement with respect to the transferred Shares. Any such transferred Shares shall remain “Shares” hereunder, and such transferee shall be treated as a
“Stockholder” for purposes of this Agreement. 
 5.05 Prohibited Transfers. 

(a) Except as otherwise provided in this Agreement, each Stockholder will not Transfer all of any part of or any
interest in the Shares. Any Transfer of Shares not made in conformance with this Agreement shall be null and void, shall not be recorded on the books of the Company and shall not be recognized by the Company. 

(b) In the event a Stockholder should sell any Shares in contravention of the co-sale rights of the Selling Holders
under Section 5.02 (a “Prohibited Transfer”), the other 

  
 -19-

 
Significant Stockholders, in addition to such other remedies as may be available at law, in equity or hereunder, shall have the put option provided below under subsection (c), and the Stockholder
shall be bound by the applicable provisions of such option. 
 (c) In the event of a Prohibited Transfer, each
Significant Stockholder shall have the right to sell to the Selling Stockholder, and such Selling Stockholder shall be obligated to purchase from such Significant Stockholder, the type and number of Shares equal to the number of Shares each
Significant Stockholder would have been entitled to Transfer to the third-party transferee(s) under Section 5.02 hereof had the Prohibited Transfer been effected pursuant to and in compliance with the terms hereof. Such sale shall be made on
the following terms and conditions: 
 (i) The price per share at which the Shares are to be sold to the
Selling Stockholder shall be equal to the price per share paid by the third-party transferee(s) to the Selling Stockholder in the Prohibited Transfer. The Selling Stockholder shall also reimburse each Significant Stockholder for any and all fees and
expenses, including legal fees and expenses, incurred pursuant to the exercise or the attempted exercise of such Significant Stockholder’s rights under Section 5.02. 

(ii) Within sixty (60) Business Days after the later of the date on which the Significant Stockholder (A)
receives notice of the Prohibited Transfer or (B) otherwise becomes aware of the Prohibited Transfer, each Significant Stockholder shall, if exercising the option created hereby, deliver to the Selling Stockholder the certificate or
certificates representing Shares to be sold, each certificate to be properly endorsed for transfer. 
 (iii)
The Selling Stockholder shall, upon receipt of the certificate or certificates for the Shares to be sold by a Significant Stockholder pursuant to this Section 5.05, pay the aggregate purchase price therefor and the amount of reimbursable fees
and expenses, as specified in subparagraph 5.05(c)(i), in cash or by other means acceptable to the Significant Stockholder. 
 5.06 Bylaw Restrictions. The Company and each Stockholder acknowledge the transfer restrictions in Section 7.10 of the Bylaws and agree that, notwithstanding anything herein to the contrary,
the provisions of this Article V shall only apply after termination of such transfer restrictions. 

  
 -20-

 ARTICLE VI 
 [RESERVED] 
 ARTICLE VII  

Miscellaneous 
 7.01 Effectiveness. This Agreement shall become effective and binding on the parties hereto on the Execution Date. This Agreement shall terminate upon the earliest to occur of: 

(a) The date upon which this Agreement is terminated in accordance with the terms of a writing signed by the Required
Stockholders; 
 (b) The closing date of any (i) merger, consolidation or other business combination of
the Company with or into any other person or any merger, consolidation or other business combination of any person with or into the Company, if as a result of such transaction the Authorized Persons would own, directly or indirectly on a fully
diluted basis, less than fifty-one percent (51%) of the equity of the entity surviving such merger, consolidation or other business combination (assuming the exercise of all outstanding options, warrants or other rights to acquire equity in
such entity) or less than fifty-one percent (51%) of the voting power of the entity surviving such merger, consolidation or other business combination (assuming the exercise of all outstanding options, warrants or other rights to acquire equity
in such entity), or the Company is not the surviving entity of such business combination, (ii) sale, lease, exchange, transfer or other disposition, in a single transaction or series of related transactions, of all or a substantial portion of
the assets of the Company to any person, or (iii) sale, lease, exchange, transfer or other disposition, in a single transaction or series of related transactions, of all or a substantial portion of the assets of any person to the Company, if as
a result of such transaction the Authorized Persons would own directly or indirectly on a fully diluted basis, less than fifty-one percent (51%) of the equity of the Company or less than fifty-one percent (51%) of the voting power of the
Company; or 
 (c) The closing date of a Qualified IPO. 

7.02 Amendments and Consents. This Agreement may be amended, and any provision hereof may be waived, only in a
writing signed by the Required Stockholders; provided, however, that: 
 (a) any amendment or
waiver that adversely affects the rights or obligations of any Stockholder under this Agreement in a manner different than other Stockholders holding Shares of the same Class shall not be effective without the consent of such Stockholder;

 (b) any amendment or waiver that materially adversely affects the relative rights or obligations under this
Agreement of Stockholders holding a particular Class of Shares, including voting rights or rights to designate representatives to the Board of Directors, in a manner different than holders of other Classes of Shares, shall also require the approval
of a majority in interest of the Stockholders holding Shares of the affected Class; and 
 (c) any amendment or
waiver of Article V shall also require the approval of a majority in interest of the Significant Stockholders. 

  
 -21-

 Notwithstanding the foregoing, the Company may amend the Schedules from time to time to
accurately reflect the Stockholders of the Company at such time (including the names and contact information for the Stockholders). 
 7.03 Notices. All notices, elections, requests and other communications to any Stockholder shall be in writing (including a facsimile, e-mail or similar writing) and shall be given to such
Stockholder at its address or facsimile number set forth on Schedule I or at such other address or facsimile number as such Stockholder shall hereafter specify in writing to the Company. Each such notice, election, request or other
communication shall be effective (a) if given by facsimile or email, at the time such facsimile or email is transmitted and an appropriate confirmation is received (or, if such time is not during a Business Day, at the beginning of the next
such Business Day), (b) if given by mail, three Business Days (or, if to an address outside the United States, seven calendar days) after such communication is deposited in the mails with first-class postage prepaid, addressed as aforesaid or
(c) if given by any other means, when delivered at the address specified pursuant to this Section 7.03. 
 7.04 No Third-Party Rights. None of the provisions of this Agreement shall be for the benefit of or enforceable by any creditor of the Company or by any creditor of any Holder. Nothing in this
Agreement shall be deemed to create any right in any Person not a party hereto, and this Agreement shall not be construed in any respect to be a contract in whole or in part for the benefit of any third party. 

7.05 Expenses of Stockholders. The expenses and fees of each party incurred in connection with its participation
as a Stockholder, including fees incurred prior to the Execution Date, shall be borne solely by such party. 

7.06 Waivers. No failure by any party to insist upon the strict performance of any covenant, agreement, term or
condition of this Agreement or to exercise any right or remedy consequent upon a breach of any covenant, agreement, term or condition shall operate as a waiver of any covenant, agreement, term or condition of this Agreement. Any Stockholder by
notice may, but shall not be under any obligation to, waive any of its rights or conditions to its obligations hereunder, or any duty, obligation or covenant of any other Stockholder. No waiver shall affect or alter the remainder of this Agreement,
and each and every covenant, agreement, term and condition hereof shall continue in full force and effect with respect to any other then existing or subsequent breach. 

  
 -22-

 7.07 No Bill for Accounting. In no event shall any Stockholder or
Holder have any right to file a bill for an accounting or any similar proceeding. 
 7.08 Integration.
This Agreement constitutes the entire agreement among the parties hereto pertaining to the subject matter hereof and supersedes all prior and contemporaneous agreements and understandings of the parties in connection therewith. No oral covenant,
representation or condition shall affect, or be effective to interpret, change or restrict, the express provisions of this Agreement. 
 7.09 Headings. The titles of Articles and Sections of this Agreement are for convenience only and shall not be interpreted to limit or amplify the provisions of this Agreement. 

7.10 Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an
original and all of which, taken together, shall constitute one and the same instrument. 
 7.11
Severability. Each provision of this Agreement shall be considered separable, and if for any reason any provision or provisions hereof are determined to be invalid and contrary to any existing or future law, such invalidity shall not impair
the operation of or affect those portions of this Agreement which are valid. 
 7.12 Aggregation of
Shares. All Shares acquired and held by a Stockholder, an Affiliate of such Stockholder or a Permitted Transferee of such Stockholder shall be aggregated together for the purpose of determining the availability of any rights of such Stockholder
under this Agreement. 
 7.13 Waiver of Partition; Nature of Interest. Except as otherwise expressly
provided in this Agreement, each of the Stockholders hereby irrevocably waives any right or power that such Stockholder might have to cause the Company or any of its assets to be partitioned, to cause the appointment of a receiver for all or any
portion of the assets of the Company, to compel any sale of all or any portion of the assets of the Company pursuant to any applicable law or to file a complaint or to institute any proceeding at law or in equity to cause the termination,
dissolution and liquidation of the Company. Each of the Stockholders has been induced to enter into this Agreement in reliance upon the waivers set forth in this Section 7.13 and without such waivers no Stockholder would have entered into this
Agreement. No Stockholder shall have any interest in any specific assets of the Company. The Shares are personal property. 

  
 -23-

 7.14 Confidentiality. Each Stockholder and the Company agrees to keep
confidential (and to use reasonable efforts to cause its respective agents and representatives to keep confidential) in accordance with its customary practices any Confidential Information and all copies thereof, extracts therefrom and analyses or
other materials based thereon, except that the Stockholders and the Company shall be permitted to disclose Confidential Information (a) to such of its respective officers, directors, employees, agents, limited partners, members Affiliates and
representatives as need to know such Confidential Information, (b) to the extent required by applicable laws and regulations or by any subpoena or similar legal process, (c) in connection with any suit, action or proceeding relating to the
enforcement of its rights under this Agreement or (d) to the extent such Confidential Information (i) becomes publicly available other than as a result of a breach of this Section 7.14 or (ii) becomes available to the Company or
the Stockholder on a nonconfidential basis from a source other than the Company or another Stockholder. For the purposes of this Section 7.14, “Confidential Information” shall mean all financial statements, certificates, reports,
agreements, information and other items and materials (including all analyses, compilations and studies prepared by any Person based on any of the foregoing) (A) received by the Company from any Stockholder or received by any Stockholder from
the Company or any other Stockholder, (B)(1) related to the Company or any service or product offered by the Company or (2) useful in the Company’s business or operations and (C) marked as confidential, other than any of the foregoing
that have been previously disclosed in a document that is available to the public. Notwithstanding the foregoing, a Stockholder or the Company may disclose and use the ideas, concepts, know-how and techniques related to such Person’s business
activities, which are contained in the Confidential Information disclosed to such Stockholder or the Company pursuant to the terms of this Section 7.14 and retained in the memories of the employees of such Stockholder or the Company who have
had access to such Confidential Information, provided that such Stockholder or the Company has not encouraged its employees to commit such Confidential Information to memory for such use or disclosure; provided, however, that
nothing contained in this sentence gives such Stockholder or the Company the right to disclose (a) the source of such Confidential Information, (b) any statistical or personnel data of any Stockholder or the Company or (c) the
business plans of the Company or such Stockholder. The provisions of this Section 7.14 shall remain operative and in full force and effect on each Stockholder for a period of three years following the date that it ceases to hold any Shares.
This Section 7.14 shall be in addition to any other Agreements relating to confidentiality that may be entered into by any Stockholders and/or the Company after the date hereof, including any user agreement relating to services offered by the
Company to its customers (including Stockholders). 
 7.15 Applicable Law. THIS AGREEMENT SHALL BE
GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF DELAWARE WITHOUT GIVING EFFECT TO THE CONFLICTS OF LAW PRINCIPLES THEREOF; PROVIDED, HOWEVER, THAT THE FEDERAL ARBITRATION ACT, AS AMENDED (THE
“FAA”), SHALL APPLY IN PLACE AND INSTEAD OF ANY DELAWARE ARBITRATION LAWS OR REGULATIONS. 

  
 -24-

 7.16 Dispute Resolution; Waiver of Jury Trial. (a) To the
fullest extent permitted by the DGCL and other applicable law, any controversy, claim or dispute arising out of or relating to this Agreement or any breach hereof, including any dispute concerning the scope of this Section 7.16, shall be
resolved exclusively by binding arbitration conducted before an arbitrator in accordance with the most applicable then existing Rules of Arbitration (the “Rules”) of the International Chamber of Commerce (“ICC”) (or any successor
or other institution performing comparable services). In order to commence a proceeding pursuant to this Section 7.16(a), any Person having rights under this Agreement (including, if applicable, the Company) shall provide written notice of such
intent to (i) each other Person having an interest in any such proceeding and (ii) if not a party to such proceeding, the Company. Within twenty (20) Business Days after notice of any such proceeding is deemed to have been given,
the parties to such proceeding shall use commercially reasonable efforts to appoint a sole arbitrator by agreement of such parties confirmed in accordance with the Rules. If an arbitrator is so appointed and if the Company is not a party to such
proceeding, the parties to such proceeding shall cause the Company to be notified of the name and contact information of such arbitrator. If the parties to such proceeding shall fail to appoint an arbitrator within the requisite time period, they
shall within twenty (20) Business Days after the expiration of such time period, use commercially reasonable efforts to appoint a former judge of an appellate court of the state in which the Company’s headquarters is located, a United
States District Court or a United States Court of Appeals, to serve as the arbitrator for the proceeding. In the event that the parties to such proceeding are unable to select an arbitrator pursuant to the immediately preceding sentence, they shall
petition the Chief Judge for the United States District Court for the District of Delaware to appoint the arbitrator. If such Chief Judge shall fail to appoint an arbitrator, the parties to such proceeding shall either (i) comply with any legal
process specified by a judge of such District Court to appoint an arbitrator or (ii) if no such process is specified, use commercially reasonable efforts to appoint a sole arbitrator by submitting an application to such District Court pursuant
to Section 5 of the FAA. The arbitration shall be conducted in the English language, and the arbitrator shall be bound to give effect to the express terms of the Agreement and may not award relief or otherwise make an award that is contrary to
such express terms. Judgment upon any such arbitration award may be entered by any Federal, state or foreign court having proper jurisdiction thereof. The Company and each Stockholder hereby consent to jurisdiction for such purposes in any Federal
or state court in the State of Delaware and irrevocably waive any objection to the laying of venue of any such action in such court or that any such court is an inconvenient forum. Unless otherwise agreed to by the parties to an arbitration, the
situs of any such arbitration shall be selected by the arbitrator, provided that such location is within 25 miles of the headquarters of the Company. The costs of the arbitration shall be borne by the parties on such equitable basis as the
arbitrator shall determine. 
 (b) WITHOUT LIMITING THE GENERALITY OF PARAGRAPH (a) ABOVE, TO THE EXTENT
PERMITTED BY APPLICABLE LAW, THE PARTIES HEREBY IRREVOCABLY WAIVE ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

  
 -25-

 (c) The provisions of this Section 7.16 shall survive the termination
of this Agreement or the dissolution of the Company. 
 7.17 Public Announcements. Neither the Company
nor any Stockholder shall, or shall permit any of the Subsidiaries to, disclose any Stockholder’s name or identity as an investor in the Company in any press release or other public announcement or in any document or material filed with any
governmental entity, without the prior written consent of such Person, which consent shall not be unreasonably withheld, unless such disclosure is required by applicable law or governmental regulations or by order of a court of competent
jurisdiction, in which case prior to making such disclosure the Company shall give written notice to such Person describing in reasonable detail the proposed content of such disclosure and shall permit such Person to review and comment upon the form
and substance of such disclosure. 
 7.18 Successors and Assigns. The provisions of this Agreement shall
be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. Notwithstanding the foregoing, neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason
hereof shall be assignable other than in connection with the transfer of a Share permitted under the Bylaws. 

7.19 Additional Purchasers. Upon the sale of additional Senior Preferred to any Additional Purchaser in accordance
with Section 1.3 of the Senior Preferred Purchase Agreement, the Company, without prior action on the part of any Stockholder, shall require each Additional Purchaser to execute and deliver this Agreement. Each such Additional Purchaser, upon
execution and delivery of this Agreement by such Additional Purchaser, shall be deemed a Stockholder hereunder. 

7.20 Pay to Play. In the event a Stockholder or its assignee does not purchase its Pro Rata Share of 15,625,000
shares of Series CC Preferred Stock proposed to be issued under that certain Series CC Purchase Agreement, dated as of June 26, 2008, as amended (“Purchase Agreement”), by the Second Closing (as defined in the Purchase
Agreement) (each a “Non-Participating Investor”), then, as of the Second Closing, such Non-Participating Investor shall no longer be entitled to the rights set forth in this Agreement, and, accordingly, shall no longer be deemed a
“Stockholder” (except as described below), “Major Stockholder”, “Participating Stockholder”, “Required Stockholder”, “Selling Holder” or a “Significant Stockholder” (except as described
below) under this Agreement. Notwithstanding the foregoing, each Non-Participating Investor shall continue to be deemed a “Stockholder” for purposes of Sections 7.03 (Notices), 7.05 (Expenses of Stockholders), 7.07 (No Bill for
Accounting), 7.13 (Waiver of Partition; Nature of Interest), 7.14 (Confidentiality), and 7.17 

  
 -26-

 
(Public Announcements). Furthermore, while each Non-Participating Investor will no longer have the rights of a “Significant Stockholder” under Article V of this Agreement, the Shares
held by such Non-Participating Investor shall continue to be subject to Article V of this Agreement such that a Non-Participating Investor may be a “Selling Stockholder” under Article V and a “Stockholder” under
Sections 5.04, 5.05(a), 5.05(b) and 5.06. For purposes of this Section, a Stockholder’s “Pro Rata Share” shall mean the percentage equal to (x) the shares of Preferred Stock held by such Stockholder immediately prior to
June 26, 2008 divided by (y) the total number of shares of Preferred Stock issued and outstanding immediately prior to June 26, 2008. [Amended on June 26, 2008 re Series CC Financing Purchase Agreement]. 

  
 -27-

 IN WITNESS WHEREOF, this Agreement has been duly executed by the parties as
of the Execution Date. 
  

			
	E2OPEN, INC.
		
	 By:
	 	  

		
	 Name:
	 	  

		
	 Title:
	 	  

	
	STOCKHOLDERS
	
	 INVESTOR

		
	 By:
	 	  

		
	 Name:
	 	  

		
	 Title:
	 	  

  
  

	
	 SIGNATURE PAGE TO E2OPEN, INC.

SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT

 SCHEDULE I 
 STOCKHOLDERS AND NOTICE INFORMATION 
  

					
	Stockholder	  	Notice Information	  	 
			
	 Acer, Inc.
	  	 Address:
	  	
		  		  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	 Hitachi Maxwell, Ltd.
	  	 Address:
	  	
		  		  	
		  		  	
		  		  	
		  		  	
		  		  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	 LG Electronics Inc.
	  	 Address:
	  	
		  		  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Email:
	  	
		  	 Attn:
	  	
			
	 Lucent Technologies Inc.
	  	 Address:
	  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	

  
 -1-

					
	Stockholder	  	Notice Information
			
	 Panasonic Corporation
	  	 Address:
	  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	 Nortel Networks Limited
	  	 Address:
	  	
		  		  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
		
		  	 With a copy to:

		
		  	 Nortel Networks, Inc.

			
		  	 Address:
	  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	 Seagate Technology LLC
	  	 Address:
	  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	 Solectron Corporation
	  	 Address:
	  	
		  		  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	 Toshiba Corporation
	  	 Address:
	  	
		  		  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	

  
 -2-

					
	Stockholder	  	Notice Information
			
	Crosspoint Venture Partners 2000	  	 Address:
	  	
	(Q), L.P.	  		  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Crosspoint Venture Partners 2000,	  	 Address:
	  	
	L.P.	  		  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Morgan Stanley Dean Witter	  	 Address:
	  	
	Venture Partners IV, L.P.	  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Morgan Stanley Dean Witter	  	 Address:
	  	
	Venture Investors IV, L.P.	  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Morgan Stanley Dean Witter	  	 Address:
	  	
	Venture Offshore Investors IV, L.P.	  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Morgan Stanley Dean Witter	  	 Address:
	  	
	Equity Funding, Inc.	  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	

  
 -3-

					
	Stockholder	  	Notice Information
			
	Chancellor V, L.P.	  	 Address:
	  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Chancellor V-A, L.P.	  	 Address:
	  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Vendanta Capital, LLC	  	 Address:
	  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Citiventure 2000, L.P.	  	 Address:
	  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	JK&B Capital IV, L.P.	  	 Address:
	  	
		  		  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	JK&B Capital IV QIP, L.P.	  	 Address:
	  	
		  		  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	

  
 -4-

					
	Stockholder	  	Notice Information
			
	B&M Ventures, LLC	  	 Address:
	  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Daitung Development and	  	 Address:
	  	
	Investment Corporation	  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Litung Venture Capital Corporation	  	 Address:
	  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Shengtung Venture Capital	  	 Address:
	  	
	Corporation	  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	Greg Clark	  	 Address:
	  	
		  		  	
			
	PACO (for the benefit of Cross	  	 Address:
	  	
	Creek Capital, L.P.)	  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	PACO (for the benefit of Cross	  	 Address:
	  	
	Creek Capital Employees’ Fund,	  		  	
	L.C.)	  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	
			
	JBM 2009 Irrevocable Trust	  	 Address:
	  	
		  		  	
		  	 Telephone:
	  	
		  	 Facsimile:
	  	
		  	 Attn:
	  	

  
 -5-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}]]